Medical connector

Information

  • Patent Grant
  • 11883623
  • Patent Number
    11,883,623
  • Date Filed
    Friday, July 24, 2020
    4 years ago
  • Date Issued
    Tuesday, January 30, 2024
    9 months ago
Abstract
A soft grip medical connector comprises a housing with an upstream end, a downstream end and a lumen extending through a central portion thereof. A flexible member comprises a valve portion integrally formed with a sleeve portion. The valve portion is positioned within a section of the housing and is configured to control a flow of fluid through the housing lumen. The sleeve is inverted to envelope at least a portion of the outer surface of the housing. In some embodiments the gripping portion is integrally formed with the valve portion. In some embodiments, the connector is also generally configured to create a positive pressure in a catheter lumen upon removal of a syringe or other medical device from the upstream end of the connector. Methods of making a medical fluid connector generally comprise forming a valve member with a sleeve extending there from, and assembling the valve, sleeve and housing.
Description
BACKGROUND OF THE INVENTIONS
Field of the Invention

The inventions disclosed herein relate in general to the field of medical connectors, and in particular to needle-less medical connectors.


Description of the Related Art

The manipulation of fluids for parenteral administration in hospitals and medical settings routinely involves the use of connectors for selectively facilitating the movement of fluids to or from patients. For example, a connector may be attached to a catheter that leads to a tip positioned within a patient, and various connectors may be attached to one or more tubes and medical implements to control the fluid flow to or from the patient.


Needle-less connectors are typically structured so that a medical implement without a needle can be selectively connected to such a connector for providing fluid flow between a patient and a fluid source or receptacle. When the medical implement is removed, the connector closes, effectively sealing the catheter connected to the patient without requiring multiple injections to the patient and without exposing health care professionals to the risk of inadvertent needle sticks. The medical implement used with the connector may be a tube or other medical device such as a conduit, syringe, IV set (both peripheral and central lines), piggyback line, or similar component which is adapted for connection to the medical valve.


Many existing medical connectors can be relatively difficult to grasp by health care professionals during use. In most applications, medical connectors are designed to be relatively small to minimize the cost of manufacturing and to minimize the amount of fluid “dead space” inside the connectors. Moreover, most medical connectors include a housing with a hard, smooth outer surface. As a result, it is sometimes uncomfortable for health care professionals to tightly pinch their fingers around the connectors and firmly grasp them during medical procedures in a repetitious manner. Because health care professionals use such connectors very frequently during patient care, enhancements in their ability to effectively grasp the connectors can result in significant improvement in the time and effort required to use them. Additionally, the existing hard-surface medical connectors can be uncomfortable against a patient's skin. This discomfort can become especially pronounced when a patient requires frequent medical attention involving the use of medical connectors, such as hemodialysis.


Additionally, many existing medical connectors at least partially obstruct fluid flow with complex flow passageways including various turns, bends, and corners. These obstructions can result in a fairly low flow rate. The obstructions can also damage blood platelets.


Further, many existing connectors permit some degree of retrograde fluid flow upon the disconnection of these medical devices from the valve. These connectors typically include an internal space through which a fluid may flow from the medical implement to the catheter attached to the connector. When the medical implement is attached to the connector, it typically occupies a portion of this internal valve space, displacing a certain amount of fluid within the connector. When the medical implement is disconnected, a vacuum is created by the removal of the portion of the medical implement from the internal space of the connector, which tends to draw fluid up through the line from the patient toward the connector to fill the space left by the removal of the implement.


This regression of fluid has certain disadvantages. When the connector is attached to a fluid line leading to a patient, retrograde movement of fluid through the line towards the space in the connector has the effect of drawing a small amount of blood away from the patient in the direction of the connector. The blood thus drawn into the catheter may, over time, result in a clog in the catheter near its tip, potentially limiting the effectiveness of the catheter tip.


The likelihood of blood clogging the tip of a catheter is heightened when the inner diameter of the catheter is small. In parenteral applications, such smaller-diameter catheters are used frequently due to their numerous advantages. For example, smaller catheters reduce the trauma and discomfort caused by insertion into a patient. Because these catheters have small lumens, even a small suction force may draw fluid back a comparatively large distance through the catheter toward the connector.


Further, in some existing medical connectors, there are gaps between an internal sealing member and the outer housing of the connector. These gaps may allow bacteria, debris, or disinfectant solution to enter through the opening into the interior of the connector and potentially reach the flow of fluid to or from the patient.


SUMMARY OF THE INVENTIONS

Certain embodiments of the present invention provide a soft-grip medical connector comprising a housing with an upstream end, a downstream end, a lumen extending through a central portion of the housing, and a flexible member. In some embodiments, the flexible member has a valve portion integrally formed with a gripping portion. The valve portion is positioned within a portion of the housing. The valve portion is configured to control a flow of fluid through the housing lumen. The gripping portion covers at least a portion of an outer surface of the housing.


In some embodiments, a medical fluid connector comprises a cylindrical body, a valve portion, and a sleeve portion. The cylindrical body has an outer wall with a plurality of flanges extending radially therefrom and a lumen extending through a portion thereof. The valve portion provides a closeable seal between a first end and a second end of the cylindrical body. The sleeve portion can be unitarily formed with the valve portion and can surround a substantial portion of an outer surface of the cylindrical body.


Methods of forming a gripping and/or sealing portion of a medical device are also provided. In some embodiments, a method comprises injecting an uncured material into a mold, thereby molding a first preform from a substantially flexible material. The preform is removed from the preform mold, and a second preform is molded (though not necessarily in the same mold as the first). The first preform and the second preform are then inserted into a final mold, and an uncured material is injected into the final mold in order to over-mold the first and second pre-forms into a final structure having a valve member and a sleeve portion extending from the valve member.


Methods of making a medical fluid connector are also provided. In some embodiments, the methods comprise the steps of forming a valve member with a sleeve extending therefrom, the valve and sleeve being integrally formed of a substantially flexible material and forming a relatively rigid housing. A portion of the valve member is inserted into a cavity of the housing such that the sleeve extends from the housing member. The sleeve is then inverted to cover or surround at least a portion of an outer surface of the housing member.


In embodiments of a method of using a soft-grip connector, the downstream end is connected to a first medical implement such as a catheter. A second medical implement is inserted into an opening in the upstream end of the connector. Upon introduction of the second medical implement into the connector, in certain embodiments, the valve member expands, creating a larger internal volume. Fluid from the second medical implement is permitted to flow into the valve member. In some embodiments, this introduction of fluid causes further expansion of the volume inside the valve member, and as the fluid flow diminishes or stops, the inside volume of the valve member contracts.


As the second medical implement is withdrawn from the connector, the internal volume of the valve member also decreases. In some embodiments, the valve member can rapidly return to its original state (i.e., before insertion of the second medical implement). A region inside of the valve member near the upstream end is narrower than a region near the downstream end to impede the flow of fluid in the upstream direction and encourage the flow of fluid in the downstream direction. In this way, fluid inside the connector is forced toward the downstream end of the connector in the direction of the patient, creating a positive flow effect and minimizing regression of fluid back into the valve. Various configurations of positive-flow valves are disclosed in U.S. Pat. No. 6,695,817 and U.S. Patent Application Publication No. 2004/0006330, owned by ICU Medical, Inc., and such documents are incorporated herein by reference and form a part of this specification for all that they disclose.


In many embodiments, the connector is small yet easily grippable. The outer sleeve can be made, for example, of silicone rubber, which creates a desirable degree of anti-slip friction against standard rubber gloves worn by health care professionals. In some embodiments, the contours of the connector in the region near the upstream end are generally smooth and seamless due to the integral formation of the flexible outer sleeve and the valve member. In this configuration, it is less likely that bacteria or other debris will gather in areas where fluid flow passes through to the patient and it is easier and more effective to swab such areas with antiseptic. The integral formation of the valve member and outer sleeve also simplifies, and increases the cost-effectiveness, of the manufacturing processes.





BRIEF DESCRIPTION OF DRAWINGS

Having thus summarized the general nature of the invention, certain preferred embodiments and modifications thereof will become apparent to those skilled in the art from the detailed description herein having reference to the figures that follow, of which:



FIG. 1 is a perspective view of one embodiment of a soft-grip medical connector including an outer sleeve surrounding a housing member;



FIG. 2 is a perspective view of one embodiment of a housing member of a soft-grip medical connector;



FIG. 3 is a top plan view of the housing member of FIG. 2;



FIG. 4 is a bottom plan view of the housing member of FIG. 2;



FIG. 5 is a transverse cross-sectional view of the housing member of FIG. 2 taken through line 5-5 (shown in FIG. 3);



FIG. 6 is a transverse cross-sectional view of the housing member of FIG. 2 taken through line 6-6 (shown in FIG. 3);



FIG. 7 is an exploded perspective view of another embodiment of housing member of a soft-grip medical connector;



FIG. 8A is a perspective view of a first housing portion of the housing member of the housing member of FIG. 7;



FIG. 8B is a perspective view of the first housing portion of FIG. 8A from a reverse angle;



FIG. 9A is a perspective view of a second housing portion of FIG. 7;



FIG. 9B is a perspective view of the second housing portion of FIG. 9A from a reverse angle;



FIG. 10 is a transverse cross-sectional view of the housing member of FIG. 7 taken through line 10-10;



FIG. 11 is a transverse cross-sectional view of the housing member of FIG. 7 taken through line 11-11;



FIG. 12 is a perspective view of a flexible member including a valve member and a sleeve connected to the valve member;



FIG. 13 is a cross-sectional view of the connector of FIG. 12, taken through line 13-13;



FIG. 14 is a cross-sectional view of the flexible member of FIG. 12, taken through line 14-14;



FIG. 15 is a perspective view of one embodiment of a preform for use in manufacturing some embodiments of a flexible member;



FIG. 16 is a perspective view of another embodiment of a flexible member including a valve member and a sleeve connected to the valve member;



FIG. 17 is a cross-sectional view of the flexible member of FIG. 16, taken through line 17-17;



FIG. 18 is a cross-sectional view of the flexible member of FIG. 16, taken through line 18-18;



FIG. 19 is a perspective view of a third embodiment of a flexible member having a valve member and a sleeve connected to the valve member;



FIG. 20 is a cross-sectional view of the flexible member of FIG. 19, taken through line 20-20;



FIG. 21 is a cross-sectional view of the flexible member of FIG. 19, taken through line 21-21;



FIG. 22 is a perspective view illustrating an assembly of a flexible member with a housing member;



FIG. 23 is a perspective view illustrating the sleeve of the flexible member adjacent to the housing member, with the valve member of the flexible member inserted into the housing member;



FIG. 24 is a cross-sectional view of an assembled soft-grip medical connector;



FIG. 25 is a cross-sectional view of a soft-grip medical connector taken at about 90° relative to the cross-section of FIG. 24;



FIG. 26 is a cross-sectional view of the connector of FIG. 24 with a syringe connected thereto; and



FIG. 27 is a cross-sectional view of the connector of FIG. 24 taken at about 90° relative to the cross-section of FIG. 26.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

With reference to the attached figures, certain embodiments and examples of soft-grip medical connectors will now be described. Although certain embodiments and examples of a soft-grip connector are shown and described as including positive-flow valves, certain aspects and advantages of the systems and methods described herein can be advantageously applied to numerous other fluid connector designs including those without positive-flow characteristics.


Referring now to FIG. 1, the illustrated embodiment of a medical connector 10 comprises a substantially rigid housing 12 with a flexible member 80 that has been stretched over the outer surface of the housing 12 to provide a soft, grippable outer surface 22. A slit opening 100 is formed at an upstream end 16 of the flexible member 80. The upstream end of the flexible member 80 surrounding the housing 12 provides a surface that is easily cleaned, and is substantially free from cavities or recesses in which contaminants may collect. While as illustrated, the upstream end of the flexible member 80 surrounds the entire circumference of the housing 12, it is contemplated that in other embodiments, the upstream end of the flexible member may circumferentially surround substantially all of the housing 12, or can circumferentially surround a portion of the housing 12 such as approximately three-quarters, approximately one-half, or less. In other embodiments, the flexible member 80 can be segmented to surround multiple portions of the housing 12. For example, the flexible member 80 can have one or more openings or perforations that expose a portion of the underlying housing 12 beneath the flexible member 80, and/or the portions of the flexible member 80 on the outside of the housing 12 can be made of strips or bands that contact the housing 12. The outer surface of the flexible member 80 can cover internal portions of the flexible member 80, such as lateral extensions 84 (discussed in further detail below), to prevent interference with those portions during use, thereby providing for more consistent functionality of the flexible member 80.


Referring now to FIGS. 2-11, embodiments of a housing 12 are described. FIGS. 2-6 depict one embodiment of a housing 12 for use in a soft-grip medical connector. FIGS. 7-11 depict another embodiment of a housing for use in a soft-grip medical connector. Many other embodiments can also be formed by using or combining one or more features of the disclosed embodiments.


With reference to the housing depicted in FIGS. 2-6, the housing 12 comprises an upper cavity 42 for receiving a flexible member 80, and interfaces 16, 30 for joining the connector to a variety of medical devices. An upper housing 40 generally comprises a cylindrical wall 44 having longitudinal slots 46 positioned on opposite sides, e.g., oriented at about 180° relative to one another. At a lower end, the upper housing 40 joins a base member 48 which comprises a lower Luer connector 30 (see, e.g., FIGS. 5 and 6). During storage and shipping of a sterilized connector 10, a protective cap (not shown) can be attached to the lower Luer connector 30 to maintain its sterility before use. The cap is generally removed by a health care professional immediately before connecting the lower Luer connector 30 to a medical implement.


As illustrated, embodiments of a housing member 12 can also include a plurality of ring sections 60 extending radially outwards from the outer surface of the cylindrical wall 44 of the upper housing 40. In some embodiments, the rings 60 are progressively smaller in diameter from top 60a to bottom 60c. In still other embodiments, the number, size, and configuration of the rings 60 can be modified in many other ways.


Flanges 62 can also be provided at the intersections between the rings 60 and the slots 46. The flanges 62 prevent lateral extensions 84 of the flexible member 80 (see, e.g., FIG. 23), when inserted into the upper housing 40, from snagging or catching on the edges of the rings 60 at the points where such rings 60 are bisected by the longitudinal slots 46. The rings 60 and flanges 62 are generally configured to retain portions of a sleeve 20 on the flexible member 80, as will be discussed in further detail below.


As illustrated in FIGS. 1, 5 and 6, the progressively smaller diameter rings 60 coupled with a frustoconically shaped skirt 52 generally result in an “hourglass” shaped housing. This advantageously assists in providing an easily grippable connector. The smaller-diameter region near the lower end of the upper housing 40 can be grasped between the thumb and index finger of a health care professional. In the region of the rings 60, the progressively larger diameter regions above and below the smaller-diameter region make it less likely that the person's grip will slide along the outside surface of the connector 10 when other medical implements are attached to it or detached from it. In addition, other gripping surfaces such as bumps, ridges, and other types of indentations or protrusions can be provided on the outside surface of the sleeve 20 in the region where the health care provider's fingers are expected to grasp the connector 10.


The dimensions of the housing 12 preferably allow for a compact connector. Advantageously, a compact connector is relatively low cost as it requires a relatively small amount of material to manufacture. Further, the compactness typically results in a lightweight connector, thus reducing irritation to a patient when a connector is rested on or hanging from the patient for a relatively long duration use. For example, in some embodiments, the housing 12 has a height from an upstream end 16 to a downstream end of a Luer cannula 32 of between about 0.400″ and 1.200″. In other embodiments, the height of the housing 12 can be between about 0.500″ and 1.000″. In still other embodiments, the height is less than 1.000″. The height of the upper housing 40 from an upstream end 16 to the lower Luer connector 30 is between about 0.500″ and 0.750″. Preferably, the upper housing 40 comprises approximately three-fourths to four-fifths of the overall height of the housing 12. A Luer cavity 74 has a height extending from the lower end 36 of the housing 12 to a lower surface of the base member 48. In certain embodiments, the height of the Luer cavity is between approximately 0.150″ and 0.350″. In other embodiments, the height of the Luer cavity is less than approximately 0.400″. In a certain embodiment, the height of the Luer cavity is approximately 0.220″. Preferably, the height of the Luer cavity 74 corresponds to a length of a Luer connector to be inserted in the Luer cavity 74 such that the Luer connector can be flushly inserted into the Luer cavity 74. Preferably, the height of the Luer cavity 74 comprises from between approximately one-eighth to approximately one-third of the height of the housing 12. In certain embodiments, a Luer cannula 32 extends past the lower end 36 of the housing 12 approximately 0.050″ to 0.150″. In other embodiments, the Luer cannula 32 extends past the lower end 36 approximately 0.80″ to 0.120″. In a certain embodiment, the Luer cannula 32 extends past the lower end 36 approximately 0.093″. Preferably, the Luer cannula is sized and configured to couple with a Luer connector to be inserted into the Luer cavity 74.


The dimensions of the rings 60 and other housing structures correspond to features of the sleeve 20 as will be further described below. For example, in some embodiments, the cylindrical wall 44 has an outer diameter of between about 0.200″ and about 0.300″, preferably between about 0.250 and about 0.275, and in one particular embodiment, a diameter of about 0.265. In such embodiments, the upper ring 60a has a height ‘h’ (i.e. the difference between the outer diameter of the ring and the outer diameter of the cylindrical upper housing) of about 0.110″ (±0.0.02″), the middle ring 60b has a height of about 0.093″ (±0.0.02″), and the lower ring 60c has a height of about 0.073″ (±0.0.02″). Thus, in certain embodiments, the housing 12 includes a generally hourglass-shaped body defined by the cylindrical wall 44 and the rings 60a, 60b, 60c and having a maximum diameter of between about 0.310″ and 0.410″, preferably between about 0.360″ and 0.385″, and in one particular embodiment, about 0.375″. Other dimensions within and outside of the above ranges can also be used depending on the particular application desired.


As shown, for example, in FIGS. 1, 2 and 5, the housing 12 can also include protrusions 70 such as lugs for receiving a threaded medical connector such as a Luer connector of a medical device such as a syringe. In the illustrated embodiment, the protrusions 70 lugs are generally rectangular in shape. The lugs can also have substantially rounded or beveled edges so as to prevent damage to the sleeve 20 of the flexible member 80 after it is stretched over the outside of the housing 12, as described in greater detail below. The sleeve 20 can include windows 126 configured to allow the protrusions 70 to protrude through the flexible member 80, while preferably tightly engaging the periphery of the protrusions 70, when the sleeve 12 is inverted (as will be discussed in further detail below). In other embodiments, the protrusions 70 can comprise other shapes and configurations as desired. In some embodiments without windows 126, the protrusions 70 are sized to cooperate with a thickness of the sleeve, such that the protrusions 70 form a lump in the sleeve sufficient to engage a female thread of a Luer connector to be attached to the upstream end 16 of the connector 10.


In some embodiments, the lower housing interface comprises a Luer connector 30 to facilitate joining the connector 10 to medical devices with female Luer connectors. The Luer connector 30 of the housing 12 can comprise a hard cannula 32 extending downwardly from the lower end 36 of the housing 12 to provide a connection with another medical device, such as a catheter hub. Other interfaces and connections can also be used in place of the Luer connector 30, such as Luer slip connections, barbed hose fittings, etc.


As shown in FIGS. 5 and 6, the housing also includes an interior cannula 50 extending into the upper housing cavity 42. The interior cannula 50 comprises a lumen 45 extending through the base member 48 and through the Luer cannula 32 of the lower Luer connector 30. The lower Luer connector 30 also includes a skirt 52 which extends downwards from the base member 48 and typically comprises internal threads 56 or other features for securing the connector 10 to another medical device. The skirt 52 can comprise a taper from a narrower upper portion to a larger-diameter lower portion. In some embodiments, the skirt 52 also includes an incut annular groove 54 around the perimeter of the skirt 52 at a lower portion thereof. This annular groove 54 can be used to retain a portion of the sleeve as will be described in further detail below.


In certain embodiments, it is desirable to provide vents 72 (see FIG. 4) between the upper housing cavity 40 and the cavity 74 defined by the lower Luer skirt 52. Since the outer surfaces of the housing 12 are generally in contact with the sleeve 20 in the final assembly (and, as discussed below in connection with assembly of the medical connector 10, in certain embodiments, the sleeve 20 can cover the entire outer surface, or nearly the entire outer surface, of the housing 12), such ventilation between the upper housing 40 and the cavity 74 is helpful in allowing air, gaseous sterilizing agents or other gases to flow freely into and/or out of the upper housing cavity. This ventilation can be particularly helpful when and as a medical implement is inserted into the slit opening 100 of the connector 10 and the flexible member 80 expands, diminishing the volume between the outer surface of the flexible member 80 and the inner wall of the upper housing 40. The vents 72 may also allow moisture and other liquids to flow freely into and/or out of the upper housing cavity, thus reducing the risk that a volume of liquid could become trapped in the upper housing 40 and restrict expansion of the flexible member 80, provide a hospitable environment for the growth of unwanted bacteria, or otherwise adversely affect the operation of the medical connector 10. Without venting, such insertion of the medical implement could be met with resistance, creating undue wear on the flexible member 80 and requiring additional effort to use the connector 10. Similarly, recessed vents 76 can be provided in the lower end 36 of the Luer skirt 52 to allow air or other gases to escape from the interior of the Luer cavity 74 while the connector 10 is attached to another medical device. Additionally, the recessed vents 76 allow air or other ambient gases to enter the Luer cavity 74 while the other medical device is removed from the medical connector 10 such that the medical device does not become vacuum locked to the medical connector 10. The recessed vents 76 also allow water, cleaning or disinfecting solutions, or other liquids to escape the Luer cavity 74 while the medical connector 10 is connected to another medical device. In some embodiments, it can be desirable to provide ventilation holes in the sleeve 20 itself.


With reference to FIGS. 7-11, in certain embodiments, the soft-grip medical connector comprises a housing formed of more than one housing portion. In the illustrated embodiments, the housing is formed of a first housing portion 41 and a second housing portion 51. FIG. 7 illustrates an exploded perspective view of a two-piece housing. FIGS. 8A and 8B are perspective views of the first housing portion 41, and FIGS. 9A and 9B are perspective views of the second housing portion 51.


In some embodiments, a two-piece housing may include many or all of the structural features of the housing illustrated in FIGS. 2-6 and described above. In other embodiments, the housing may include more than two pieces. The two-piece housing illustrated in FIGS. 7-11 includes protruding lugs 71 for receiving a threaded medical connector such as a Luer connector of a medical device such as a syringe. The first housing portion 41 also includes longitudinal slots 49 oriented at approximately 180° relative to each other. In some embodiments, a different number of slots or ridges can be provided and the slots or ridges can be of sizes or positions. The first housing portion 41 defines an upper cavity 43 for receiving a flexible member 80. The second housing portion 51 includes a threaded Luer cavity 59. Additionally, the second housing portion may include recessed vents 77 in the lower surface of the Luer cavity 59. The second housing portion includes an interior cannula 53 comprising a lumen 55 extending through the second housing portion 51. Moreover, the second housing portion may include vents 57 between the first housing portion 41 and the second housing portion 51. Further, it is contemplated that a two-piece housing can have dimensions corresponding to the ranges discussed above with respect to the embodiments of one-piece housing 12 illustrated in FIGS. 2-6. Therefore, in certain embodiments of medical connector, a two-piece housing could be used interchangeably with a one-piece housing.


The two piece housing illustrated in FIGS. 7-11 also can also include additional features. For example, the two-piece housing can include various alignment and coupling features to ease assembly of the first housing portion 41 with the second housing portion 51 into a complete housing. For alignment, the second housing portion may include at least one ridge 65, and the first housing portion at least one corresponding recess 63. As illustrated in FIG. 7, the ridge 65 and sidewall 63 are configured to align the first housing portion 41 in a desired orientation with the second housing portion 51 during assembly of the housing. To retain the housing in a coupled orientation, the first housing portion 41 includes at least one tab 89, and the second housing portion 51 includes at least one recess 85 configured to receive the tab 89. As illustrated, the tab 89 has a wedge-shaped profile including a lead-in surface and an interference surface such that the lead in surface facilitates insertion of the tab 89 into the recess and the interference surface prevents withdrawal of the tab 89 from the recess 85. While described herein and illustrated in terms of certain structures, it is contemplated that other alignment and coupling features can be used to couple the two housing portions 41, 51.


In the housing illustrated in FIGS. 7-11, the assembly of first and second housing portions 41, 51 results in a space 61 between the housing portions 41, 51. Advantageously, the space 61 may be sized and configured to retain an end of a flexible member 81. Thus, in such a configuration, the rings 60 used in one-piece housing 12 (FIGS. 2-6) need not be present on a two-piece housing to reduce slippage of the housing relative to a flexible member 80 disposed thereon. In order to further reduce slippage of a flexible member 80 relative to the housing, an area of the first housing portion adjacent the lugs 71 may include a recess 73 to receive an adhesive such that the flexible member 80 may be adhered to the housing. The adhesive and housing materials should be chosen to be compatible. For example, a silicone-based adhesive may be applied to adhere a glass-reinforced thermoplastic polyester resin housing to a silicone rubber sleeve 20. In addition to the slippage reduction noted above, the two-piece housing depicted in FIGS. 7-11 may be manufactured quickly and inexpensively in two separate one-step molding processes as opposed to a two-step molding process required to manufacture a more complex single-piece housing.


As illustrated in FIGS. 12-14, in some embodiments, the valve member 14 and sleeve 20 are unitarily formed in a flexible member 80. The flexible member 80 is shown removed from the housing 12 to emphasize details. Some embodiments of valve member 14 have a seal body 82 which may take the form of a slab-like structure that is relatively thin in one dimension and relatively wide in another. The valve member 14 is configured to selectively seal the connector. The term “seal” is used herein for convenience to refer to structures capable of impeding fluid flow but does not necessarily denote that such structures, either alone or in combination with other structures, form a barrier that is completely impermeable to fluid flow. In some embodiments, the body 82 comprises lateral extensions 84 extending laterally from the body 82. The body 82 can also comprise a flat, generally rectangular neck 86 and a transverse flange 90. In some embodiments, the sleeve 20 is integrally formed with the flange 90 and extends axially away from the seal body 82.


The neck 86 is positioned between first and second lateral extensions 84, which each have shoulders 92 comprising those portions of the lateral extensions nearest the flange 90. The body 82, neck 86, flange 90, and sleeve 20 can thus form an integral unit. The body 82 is generally configured to include a narrow passageway or slit 94 extending through the body 82. The slit 94 generally extends through the body 82 including the neck 86 and the flange 90. In FIG. 14, the vertical cross-sectional plane of the drawings coincides with the vertical plane of the slit 94, revealing the wide horizontal width of the slit 94 on the downstream end in this dimension. The slit 94 also includes tapering sides 95, and a narrower neck 97. FIG. 13 demonstrates the narrowness of the slit 94 in a cross-sectional plan orthogonal to the cross-sectional plane of FIG. 14.


As will be described more fully below, the valve member 14 is inserted into the cavity 42 of the housing 12. The slit 94 is generally sized and shaped to permit insertion of a cannula of a syringe or other medical device therein. The connector can be adapted to receive an ANSI standard syringe Luer tip. In some embodiments, the slit 94 is configured to assist in producing a valve that exhibits positive flow characteristics.


The slit 94 extends from the slit opening 100 in the flange 90 to a lead lumen 102 formed in a the downstream end of the body 82 opposite the flange 90. In some embodiments, the lead lumen 102 can be substantially cylindrical and centered about an axis that is substantially parallel to or collinear with the longitudinal axis of the valve member 14. The lead lumen 102 can also be provided with an enlarged external diameter section 104 (e.g. see FIG. 14) configured to aid in positioning the lead lumen 102 over the interior cannula 50 of the housing 12 and to avoid unduly diminishing the cross-sectional area for fluid flow after the flexible member 80 is so positioned.


As illustrated in FIG. 13, some embodiments of the slit 94 can be substantially planar and have a very small thickness in the undisturbed state (i.e. when a syringe cannula is not inserted into the valve member 14). The slit 94 thus forms a selectively restricted fluid flow path from the slit opening 100 to the lead lumen 102. Preferably, the flow path permits either no fluid, or a clinically negligible amount of fluid, to pass through the flexible member 80 under the various standard fluid pressure conditions of patient treatment.


The slit 94 is generally configured to provide a sealable fluid pathway between the slit opening 100 and the lead lumen 102. In some embodiments, the slit 94 can be configured as shown and described herein or as shown and described in any of the patents and applications incorporated herein by reference. The slit 94 is typically made to have essentially no space between adjacent faces of the slit. Examples of methods for making a suitable seal are described in further detail below.


In the embodiment illustrated in FIG. 12, the lateral extensions 84 generally comprise polygonal, angular shapes, although other suitable shapes can be used in view of particular design objectives. The lateral extensions 84 are generally configured to provide structures that interact with portions of the housing 12 in order to retain the valve member 14 in the housing 12 at a desired orientation. As illustrated in FIG. 12, dimples 110 can be formed in the flat surfaces of the lateral extensions 84. In other embodiments, dimples 110 can be formed on another surface of the valve member 14, and, in still other embodiments, the valve member 14 does not include dimples 110. The dimples 110 can be used for retaining and positioning the valve member 14 and lateral extensions 84 during molding and assembly of the connector as will be further described below.


In the embodiments of FIGS. 13 and 14, a sleeve 20 extends axially from the transverse flange 90 of the valve member 14 to the opposite end of the flexible element 80. The sleeve 20 can comprise a first section 112 with a first diameter D1 substantially corresponding to the diameter of the transverse flange 90, and a second section 114 with a second diameter D2 that is slightly larger. In some embodiments, the length of the first section 112 having the first diameter D1 is approximately equal to a distance between the upstream end 16 of the housing 12, and the upper ring 60a of the housing 12. The second section 114 of the sleeve 20 is typically sized to be approximately the same diameter as, or slightly smaller than, the narrowest portion of the hourglass-shaped housing. Thus, when the sleeve 20 is inverted and stretched to surround the housing 12, the sleeve 20 will preferably cling tightly to the exterior surface of the housing along substantially the entire length of the housing 12.


To retain the sleeve 20 in an inverted position surrounding the housing 12, the sleeve 20 can be provided with retaining structures to engage portions of the housing 12. Such retaining structures can include any of a variety of structures, such as protrusions, ribs, ridges, and constrictions. In the embodiments illustrated in FIGS. 12-14, the sleeve 20 comprises a plurality of protrusions 120. In other embodiments, continuous annular ribs can be used in place of the protrusions. Such annular ribs may tend to buckle when the sleeve is turned inside-out, thus causing ripples and irregularities in the outer surface of the finally assembled device. Thus, rows of protrusions 120 such as those illustrated in FIG. 12 are used in many embodiments to allow the sleeve 20 to lie more smoothly on the outer surface of the housing 12. The rows are generally configured such that adjacent protrusions abut one another without deforming the sleeve 20 when the sleeve 20 is inverted. Each of the protrusions 120 can have many shapes including rectangular, circular, and/or elliptical shapes.


The protrusions 120 can be provided in annular rows generally configured to correspond to the spaces between the rings 60 of the housing 12. The length of each row is generally also sized to allow the protrusions to lie between the linear flanges 62 adjacent the slots 46. In other embodiments, the sleeve protrusions 120 and/or the rings 60 and flanges 62 of the housing 12 can be provided in any pattern of cooperating structures to allow the sleeve 20 to be retained against axial and/or rotational movement relative to the housing 12. For example, in some embodiments, the sleeve 20 further comprises recesses or windows 126 for receiving and surrounding portions of the housing, such as the Luer protrusions 70 (see FIG. 1). In other embodiments, as discussed above with reference to the two-piece housing of FIGS. 7-11, the housing does not have rings 60, so the flexible member need not have protrusions (see FIGS. 16-18).


In the illustrated embodiment, the sleeve 20 comprises a constriction 122 surrounding the opening 124 of the sleeve 20. The constriction 122 generally comprises a section of the sleeve with a reduced diameter as compared to the second section 114. The constriction 122 can be configured to engage a feature on the housing 12 such as the annular groove 54 (see e.g. FIGS. 24 and 25) when the sleeve 20 is inverted over the housing 12. In other embodiments, the constriction 122 can be configured to engage and be retained by a space 61 between a first housing portion 41 and a second housing portion 51 (see FIGS. 10 and 11).


As described previously, some embodiments of a sleeve 20 can be provided with one or more windows 126 to accommodate and surround one or more structures on the housing such as protrusions 70 (also referred to as Luer lugs) or sized to receive a standard Luer connector. In such embodiments, the windows 126 can be molded to include thicker edges to prevent undesirable tearing of the sleeve material during assembly or use.


Moreover, as previously described, in some embodiments the sleeve 20 is not formed integrally with the valve member 14. The sleeve 20 can also be formed by adhering, coating, or otherwise providing an outside surface on the housing 12 with a suitable gripping region (instead of mechanically stretching a separately formed sleeve member over the outside surface of the housing 12). The sleeve 20 can also be formed as a band or clip that extends around only the portion of the housing 12 where the fingers of the health care provider are expected to grip the connector 10. Also, in certain embodiments, the connector 10 may be constructed without a sleeve 20.


In the embodiments depicted in FIGS. 16-18, a flexible member 81 includes at least one stiffening rib 87 oriented substantially along a longitudinal axis of the valve member 14 and protruding transversely to the flat surfaces of the lateral extensions 84. FIG. 16 illustrates a perspective view of various embodiments of flexible member 81 including two stiffening ribs 87, and FIGS. 17 and 18 illustrate cut-away views of the flexible member 81 of FIG. 16. In the illustrated embodiments, the flexible member 81 is configured to be assembled with a housing lacking rings 60 as the flexible member 81 does not include any protrusions 120 (see FIGS. 12-14). In other embodiments, a flexible member can include both a stiffening rib 87 and protrusions 120 for application to a housing having rings 60 such as is illustrated in FIG. 2.


The stiffening ribs 87 can provide resiliency and durability to the valve member 14. In some embodiments, the ribs 87 can help the valve member 14 to resist crumpling in a substantially longitudinal direction upon insertion of a medical implement into the slit opening 100. Such crumpling could block or restrict fluid flow, prevent the connector from closing, or otherwise result in some degree of inconsistent performance. Since the crumpling tendency could be exacerbated by aging of a medical connector and repeated usage cycles, the stiffening ribs can greatly extend the lifespan of a valve member 14 in a medical connector. In some embodiments, additional structures and/or materials can be used in the medical connector 10, either in combination with or absent stiffening ribs 87, to resist crumpling of the valve member 14. For example, the valve member 14 may be constructed of a material selected to be flexible enough to permit insertion of a medical implement into the slit opening 100, but stiff enough to resist crumpling over repeated usage cycles. Likewise, a desired balance between flexibility and valve longevity and resistance to crumpling may be achieved by selecting a desired thickness of the valve member 14 (with relatively thicker material used in the valve member 14 increasing the valve longevity and crumple resistance at the expense of flexibility and ease of insertion of medical implements into the slit opening 100). For example, in some embodiments, the thickness of the wall of the valve member 14 across most, nearly all, or all of its outside surface area can be about as thick as the wall of the valve member 14 plus a stiffening rib 87. In some embodiments, the thickness of the wall of the valve member 14, in at least some regions, is at least as large as, or at least about 1½-2 times as large as, the diameter of the lead lumen 102.


Another embodiment of flexible member 83 for use in a soft-grip medical connector that is configured to extend the usage lifespan of a valve member is illustrated in FIGS. 19-21. FIG. 19 illustrates a perspective view of the flexible member 83. As illustrated in FIG. 19, the flexible member 83 may share many external features with other embodiments of flexible member 80, 81 as previously discussed (including but not limited to those that are illustrated in FIGS. 19-21). For example, the flexible member 83 includes a valve member 153 and a sleeve 165. In certain embodiments, the sleeve 165 includes protrusions 157 for coupling with corresponding flanges on a housing. The sleeve 165 includes a constriction 161 surrounding an opening 163. The sleeve can include one or more windows 159 to accommodate and surround one or more protrusions 70 or other structures on the housing. The flexible member includes a transverse flange 155, a neck 167, and lateral extensions 169. As illustrated in FIGS. 20 and 21, the flexible member 83 includes a lead lumen 173 having a downstream opening 151.


As illustrated in FIGS. 20 and 21, which present cut-away views of the flexible member 83 of FIG. 19, the internal structure of the embodiments of flexible member 83 illustrated in FIGS. 19-21 can include features absent from other embodiments of flexible member 80, 81 illustrated herein. The valve member 153 of the flexible member comprises a pair of opposing sidewalls 177, 179 that intersect at an upstream end of the valve member 153 to form a slit 171 configured for insertion of a medical implement. In an undisturbed state, the slit 171 provides a sealed closure of the medical device to prevent the passage of fluid therethrough. In the downstream direction, the sidewalls 177, 179 diverge such that in an undisturbed state, a passage 175 defined by the valve member has a non-zero volume. Thus, unlike the previously-described flexible member 80, 81 embodiments, this flexible member 83 does not have a passage that is substantially planar in an undisturbed state.


In some embodiments, this non-zero volume of the passage 175 in an undisturbed state can prevent the illustrated embodiment of flexible member 83 from exhibiting positive flow characteristics when a medical implement inserted completely into the slit 171 is removed under certain circumstances. This passage 175 configuration has certain other advantages. As previously noted, the flexible member 83 resists crumpling. The divergence of the sidewalls 177, 179 enhances the durability of the valve member 153 as compared with planar sidewalls of other flexible member 80, 81 embodiments.


Additionally, the slit 171 of the flexible member 83 has a relatively small region of contact between the sidewalls 177, 179. The small region of contact results in a corresponding small resistance to flow in an undisturbed state. Thus, the flow through the valve member can be quickly initiated by inserting a medical implement only partially into the passage, or even merely positioning the medical implement adjacent to, but not within, the slit 171. Thus, either the tip of the implement or the pressure of the fluid flow breaks contact of the sidewalls 177, 179 at the slit 171 to open the valve. Advantageously, where partial insertion of, or merely adjacent contact with, a medical implement is performed, the valve member 153 may exhibit positive flow characteristics as the interior volume of the passage 175 in the undisturbed state is smaller than the interior volume of the passage 175 in the partially inserted state.


Furthermore, if, as in the illustrated flexible member 83, the passage 175 does not configured to provide positive flow characteristics on complete insertion of a medical implement, the passage 175 of the flexible member 83 need not include a region of relatively larger width. Thus, the passage 175 and the lateral extensions 169 of the flexible member 83 can be relatively narrow. Correspondingly, the housing can have a relatively smaller diameter as compared with a positive flow medical connector. Thus, a reduction in materials costs and connector weight could be achieved with a non-positive flow embodiment of flexible member 83.


Embodiments of methods for making the valve member 14 of the flexible connectors 80, 81 will now be discussed with reference to FIGS. 12-18. In general, a valve member 14 for use in the present system can be made according to any suitable process available to those of skill in this field. In some advantageous embodiments, the valve member 14 is built by molding first and second “pre-forms” 130 which are then placed face to face within a second mold. The pre-forms 130 are then over-molded in a separate molding process to form an integral flexible member 80 with valve member 14 and sleeve 20 portions such as those shown and described herein.


In one embodiment, a valve member 14 can be molded according to the general process described in U.S. Patent Application Publication No. 2004/0006330. A pair of preforms are molded between first and second mold pairs. After this initial molding step, the mold halves with the preforms still positioned therein, are pressed together with an overmold plate positioned between the mold halves. The overmold plate is generally configured to produce the final shape of the valve member 14. With the mold apparatus (including the preform mold halves and overmold plate) fully assembled, additional uncured material is then injected into the mold apparatus to fill the additional space in the mold cavity created by the overmold plate, thereby forming the remainder of the valve member 14. In some embodiments, the overmolding method described in the '330 publication can be adapted to form a valve member 14 with an integral sleeve as described herein. Alternatively, a valve member 14 can be molded according to the method of the '330 patent, and a sleeve 20 can be subsequently joined to the valve member 14 by any suitable process such as molding, welding, or adhesives.


Another embodiment of an overmolding method is provided with reference to FIG. 15. According to this method, preforms 130 are molded and completely removed from their molds prior to performing an overmolding or joining step. FIG. 15 illustrates one embodiment of a preform 130 for use in forming a valve member 14. Each preform 130 has a generally planar face 132 that, in the completed valve member 14, forms a wall of the slit 94. A flange portion 134 is also integrally molded with each preform 132. The sides of the flange portion 134 can be set back from the face 132 of the planar portion in order to provide a space 136 for overmold material to flow between and connect the flange portions 134 of two preforms 130. The molding of the preforms 130 is typically accomplished by injecting a thermoset material into the cavity formed between the mold pairs and heating the molds and/or material to the set temperature of the specific material used. Pressure may be applied as needed to prevent material from leaking between the halves of the preform mold (not shown). In some embodiments, the preforms 130 can be provided with dimples 110 on a back side 138 opposite the face 132.


After each preform 130 is molded, it can be removed from the preform mold and placed into an over-mold. The over-mold is generally configured to form a final desired valve member/sleeve structure 80. In some embodiments, an overmold comprises first and second halves. Each half can comprise pins configured to locate the preforms 130 in the overmold by aligning the pins with dimples 110 in the preforms 130.


Once the preforms are properly located in the overmold halves, the overmold halves can be brought together and an uncured overmolding material can be injected into the mold cavity. In some embodiments, the additional (overmolding) material is injected soon (i.e., a few seconds) after the preforms 130 are molded and while they are still somewhat hot from their initial molding. The additional material injected into the mold cavity bonds to the edges of the preforms 130 and forms the edges of the slit 94 in the completed valve member 14 and sleeve 20. In this way, the remainder of the valve member 14 and the sleeve 20 are overmolded and integrally formed with one another and with a pair of preforms during the over-molding step.


In some embodiments, the preforms 130 are pressed together with sufficient force during the overmolding process to prevent the overmolding material from migrating between the contacting surfaces of the preforms 130. This preserves the patency of the slit 94 by preventing the contacting faces of the preforms 130 from bonding to each other during the overmold step.


In other embodiments of this method, additional material is allowed to flow between and bond the contacting faces of the preforms to one another. Subsequently, the valve member 14 can be re-opened by inserting a blade between the preforms, thereby cutting open the slit 94. In still another embodiment, the entire valve member/sleeve structure can be molded in a single process (i.e. without a pre-formed slit), and a slit 94 can be subsequently formed by inserting a blade into a solid valve member section. In another alternative embodiment, a sleeve 20 and valve member 14 can be individually pre-formed and subsequently attached to one another, such as by overmolding, welding or with adhesives.


In some embodiments, the material added in the overmold step is similar to that utilized in molding the preforms 130. However, in other embodiments the preform material and the overmold material may comprise different but nonetheless suitable materials for manufacturing the valve member 14 and sleeve 20.


In general, the sleeve 20 is typically made of a material with sufficient flexibility to allow the sleeve 20 to be inverted and stretched around the housing 12, and sufficient resilience to tightly grip the housing 12 in the inverted orientation. Similarly, the valve member 14 is typically made of a material that is sufficiently flexible to allow a cannula to be inserted therein to open the slit, and also has sufficient resilience to re-close the valve member 14 once the cannula is withdrawn. In some embodiments, the valve member 14 and the sleeve 20 are unitarily formed of an elastomeric material such as silicone rubber. In one preferred embodiment, the valve member 14 and sleeve 20 are integrally molded from 50 durometer silicone rubber. Alternatively, the valve member 14 and sleeve 20 can be made of synthetic polyisoprene, other silicone rubber and/or urethane formulations, or other materials acceptable for medical use. In some embodiments, the sleeve 20 can be molded from a first material, and the valve member 14 can be molded from a second, different material.


Some embodiments of a flexible member 83 (FIGS. 19-21) not including positive flow characteristics can be more efficiently manufactured. The manufacture of a flexible member 83 as illustrated in FIGS. 19-21 can be accomplished with fewer steps and, accordingly, lower costs than other embodiments featuring positive flow functionality. The relatively small region of contact between the sidewalls 177, 179 facilitates manufacture of the flexible member 83 embodiments illustrated in FIGS. 19-21.


With reference now to FIGS. 22-25, embodiments of a method of assembling a soft grip medical connector 10 will be described. The valve member 14 can be inserted into the upper housing cavity 42 portion of the housing 12 by partially folding or compressing the lateral extensions 84 inwards and pushing the valve member 14 into the upper housing cavity 42 until the compressed or folded lateral extensions 84 reach the slots 46 and are permitted to uncompress or unfold and extend through the slots 46 to the outside of the housing 12. In some embodiments, tooling can be employed to grasp the lateral extensions 84 and pull the valve member 14 into the upper housing cavity 42. In some of these embodiments, the tool can be configured to engage the dimples 110 in the lateral extensions 84 to grasp and pull the valve member 14. As the lateral extensions 84 are aligned and pulled or pushed through the slots 46, an additional downward force can be applied to slightly stretch the valve member 14 and allow the shoulders 92 to engage the top edges 140 of the slots 46. In this way, a preload (discussed in further detail below) can be applied to the valve member 14. This downward force also allows the lead lumen to more securely engage the interior cannula 50 within the housing 12.


Once the valve member 14 is fully inserted into the upper housing 40 (e.g. as shown in FIG. 25), the sleeve portion 20 can be inverted and stretched over the housing 12. This can be accomplished using any suitable tooling. The sleeve 20 can also be grasped by a person's fingers and pulled outwards and downwards in the direction of the arrows 146 in FIG. 23. As the sleeve 20 is inverted, the protrusions 120 will generally align with the spaces between the rings 60 of the housing 12. If provided, the windows 126 will also be aligned with the protrusions 70 so that the protrusions 70 pass through and extend beyond the flexible member 80.


When a cleaning solution or other liquid is applied to the medical connector 10, the liquid may seep around the protrusions 70 between the sleeve 20 and the housing 12, thus causing the sleeve to slip relative to the housing 12 and making it more difficult for a health care professional to grip the outside surface of the medical connector 10. To reduce the risk that the sleeve 20 will slide or separate from the housing 12, the sleeve 20 can be adhered to the housing 12. Additionally, in various embodiments, the sleeve 20 may be stretched over an annular groove 54 (FIG. 24) or sandwiched in a space 61 between housing portions 41, 51 (FIGS. 10, 11) to reduce the risk of slippage. Before the sleeve 20 is inverted and stretched over the housing 12, an adhesive can be applied to the housing 12 or the sleeve 20 in a location of contact between the sleeve 20 and the housing 12 of an assembled connector 10. For example, in certain embodiments, the housing may include a recess 73 (FIG. 11) adjacent the Luer lugs 71 to which adhesive may be applied. Alternatively, adhesive may be spread over an outer surface of the housing 12.


Preferably, the housing 12, sleeve 20, and adhesive are chosen of compatible materials to reduce the risk of material degradation due to the application of adhesive. For example, the sleeve 20 can be constructed of a silicone rubber, to be bonded with the housing 12 with a silicone-based adhesive such as an adhesive comprising dimethylpolysiloxane. In certain embodiments, the adhesive may require the mixture of two components, at least one of which includes a catalyst such as a platinum-based catalyst. In certain embodiments, the adhesive may require curing such as, for example, by heating the adhesive to a predetermined temperature for a predetermined time. For material compatibility with a silicone-based adhesive, the housing 12 can be constructed of a glass-reinforced thermoplastic polyester resin, such as, for example, glass-filled Valox® including approximately 30% glass fill, produced by General Electric Company. In some embodiments, the housing 12 can be constructed of a polycarbonate material, although in some situations the polycarbonate may not be compatible with a silicone-based adhesive.



FIGS. 24 and 25 illustrate cross-sectional views of embodiments of a fully assembled soft grip medical connector 10. In the illustrated embodiment, the sleeve 20 fully surrounds the housing 12 including the upper housing 40, the rings 60, and a substantial portion of the Luer skirt 52. But, it is contemplated that in other embodiments, the sleeve 20 may extend over a portion of the housing 12. For example, in certain embodiments, the sleeve may extend from the upstream end 16 of the housing 12 downward over between approximately one-half a height of the upper housing 40 and the entire upper housing 40. In other embodiments, the sleeve 20 may extend from the upstream end 16 of the housing 12 downward over between approximately one-fourth the height of the upper housing 40 to one-half the height of the upper housing 40. Likewise, in embodiments of medical connector 10 including a two-piece housing, as illustrated in FIGS. 7-11, in various embodiments, the sleeve 20 can surround a portion of the first housing portion 41, substantially all of the first housing portion 41, all of the first housing portion and a portion of the second housing portion 51, or all of the first housing portion and substantially all of the second housing portion 51. The sleeve 20 can also surround the lateral extensions 84 extending through the slots 46 of the housing 12.



FIGS. 24 and 25 illustrate an example of an assembled connector in a sealed state (i.e., in which fluid flow through the connector is impeded). The valve member 14 is positioned within the upper housing cavity 42 of the housing 12, with the first and second lateral extensions 84 of the valve member 14 protruding from the first and second slots 46 in the housing 12. The lead lumen 102 of the valve member 14 is positioned so that the interior cannula 50 extends at least partway into the lead lumen 102 of the valve member 14, facilitating fluid communication between the valve member 14 and the Luer cannula 32 when the connector is in the open state (as illustrated in FIGS. 15 and 16). The flange 90 covers the axial opening at the upstream end 16 of the housing 12.


The sleeve 20 on the outside surface of the housing 12 allows health care providers to more comfortably and effectively grasp the connector 10. The flexible material of the sleeve 20 provides a softer surface for the fingers. There is preferably a high-friction interface between the flexible material of the sleeve 20 and the rubber gloves typically worn by health care providers, requiring less finger-pinching effort to screw the connector 10 onto a catheter or other medical implement and to maintain the connector 10 in a desired position and orientation during the connection and fluid-administration processes.


In addition to providing a soft, easily grippable outer surface, the sleeve 20 surrounding the exterior of the housing 12 protects the lateral extensions from being pinched or otherwise undesirably manipulated during handling and use of the connector. In one embodiment, the valve member 14 and housing 12 are constructed such that the distance between the upstream end 16 and the top edges 140 of the slots 46 of the housing 12 is slightly larger than the distance between the flange 90 and the shoulders 92 of the lateral extensions 84 of the valve member 14. This arrangement results in the application of a tensile force or preload to the valve member 14 between the flange 90 and the lateral extensions 84.


The preload arises as the shoulders 92 bear against the top edges 140 of the housing and the seal flange 90 bears against the upstream end 16 and/or the shoulder 142 of the axial opening at the upstream end of the housing. In some embodiments, the preload causes the flange 90 to assume a slightly bowl-shaped or concave configuration as the edges of the upstream housing end 16 bear against the underside of the flange 90. The bowl-shaped flange 90 tends to more tightly pinch closed the slit opening 100 and thus enhances the ability of the valve member 14 to prevent fluid flow. The preload also prevents buckling of the valve member 14 along its longitudinal axis and maintains the sides of the slit 94 in close proximity to each other along their entire length. The preload thus promotes a relatively thin slit 94 below the flange 90, which enhances the sealing performance of the slit 94. In some embodiments, a distance between the shoulders 92 and the opening 148 of the interior cannula 50 is sized such that the lead lumen 102 of the valve member 14 will be engaged with and sealed to the interior cannula 50 of the housing 12.


Referring now to FIGS. 26 and 27, during use of the connector 10, a cannula 200 of a medical device 202, such a syringe, can be inserted into the valve member 14 of the connector 10, thereby opening the valve member 14 to fluid flow 204 between the medical device 202 and the Luer cannula 32 of the connector 10.


Before the cannula 200 is inserted, the connector 10 is in a sealed state (see, e.g., FIGS. 24 and 25). In this state, the slit 94 defines a substantially closed or highly restricted flow path through the valve member 14. As illustrated in FIG. 16, when the cannula 200 is inserted through the slit 94, the valve member 14 opens a fluid flow path within the connector 10 while exerting an inwardly directed force against the cannula 200 of the medical device 202, preferably forming a tight seal around the circumference of the cannula 200 to prevent leakage of fluid through the upstream end of the connector 10. The insertion of the cannula 200 into the valve member 14 also causes the valve member 14 to stretch in the downstream direction over the interior cannula 50.


As fluid is injected from the medical device 202, through the cannula 200, and into the interior space within the valve member 14, the space between the slits walls 206 increases further and the slit walls 206 expand further and lengthen further in the downstream direction. The valve member 14 thus selectively permits fluid 204 to flow between a medical device 202 on the upstream end of the connector 10 and a medical implement (not shown) to which the lower Luer connector 30 is attached.


As shown in FIGS. 26 and 27, when in an open state, the connector 10 permits fluid flow 204 that is preferably substantially unobstructed and linear. This generally allows the connector to achieve higher flow rates. In some embodiments, the fluid flow rates through the connector 10 can exceed 600 cubic centimeters per minute. In addition, the unobstructed and linear fluid flow 204 interferes less with the inherent qualities of the flowing fluid 204. For example, if the fluid flow 204 is blood, the various blood cells and other constituents are less likely to break down within the illustrated connector 10 as compared to a connector in which there is a circuitous fluid flow path with fluid turbulently strikes against hard and/or angular internal surfaces.


As the fluid flow 204 diminishes and/or the cannula 200 of the medical device 202 is withdrawn from the valve member 14, the slit walls 206 retract and return to their original configuration to once again define a narrow, restrictive path width between them (as illustrated, for example, in FIGS. 24 and 25). This retraction of the slit walls 206 causes the volume within the slit 94 to decrease to a certain minimum. The retracting action of the slit walls 206 also forces out the remaining fluid in the area between the walls 206. As the syringe cannula 200 is being withdrawn, the displaced fluid cannot flow out of the slit 94 through the upstream end of the valve member 14 because this space is occupied by the syringe cannula 200. The resilient narrow neck 97 of the slit 94 preferably blocks any significant flow of fluid between the outer surface of the cannula 200 and the inner surface of the flexible member 80 by forming a tight seal around the circumference of the cannula 200. Thus, the displaced fluid is instead forced downwardly from the slit 94, through the interior cannula 50 and downwardly directed cannula 32, and ultimately out of the housing 12. This advantageously results in automatic positive flow from the connector 10 toward the patient upon withdrawal of the medical device 202 from the upstream end of the connector 10, and avoids or minimizes retrograde fluid flow toward the connector 10 and away from the patient.


Although the foregoing description refers to a syringe, it is contemplated that any type of suitable medical devices may be joined to either end of the connector 10, such as IV bags, other connectors, and tubing, for the purposes of fluid transfer or for any other desired purpose. An auxiliary connector also may be connected to the soft grip connector, and both connectors can be placed in fluid communication with a catheter with an end positioned within a patient. This arrangement can provide several advantages in situations which call for the use of a unique auxiliary connector. For example, when it is necessary to replace or reconfigure fluid lines connected to auxiliary connectors, such lines may be removed from fluid communication with the catheter without creating a backflow in the catheter, and replaced with a similar connector or any other medical implement. In some embodiments, one such auxiliary connector may be the CLAVE® connector sold by ICU Medical, Inc. However, any connector or other medical implement or device may be placed in fluid communication with the soft grip connector 10 to introduce fluid to the patient or to withdraw blood from the patient including, but not limited to, pierceable connectors, needle-less connectors, medical tubing, syringes or any other medical implement or device.


Although certain embodiments and examples have been described herein, it will be understood by those skilled in the art that many aspects of the methods and devices shown and described in the present disclosure may be differently combined and/or modified to form still further embodiments. For example, the various embodiments of housing may be interchangeable applied to the various embodiments of flexible member to achieve multiple embodiments of soft-grip medical connector. Additionally, it will be recognized that the methods described herein may be practiced using any device suitable for performing the recited steps. Such alternative embodiments and/or uses of the methods and devices described above and obvious modifications and equivalents thereof are intended to be within the scope of the present disclosure. Thus, it is intended that the scope of the present invention should not be limited by the particular embodiments described above, but should be determined only by a fair reading of the claims that follow.

Claims
  • 1. A soft grip medical connector comprising: a rigid housing comprising an upstream end and a downstream end, wherein the upstream end is configured to receive a Luer connector of a medical device to provide fluid communication between the medical device and the medical connector;a fluid pathway between the upstream end and the downstream end;a gripping portion between the upstream end and the downstream end, the gripping portion comprising: a tapered portion that is inwardly tapered towards the downstream end such that the gripping portion is configured to impede a finger and thumb from slipping when gripping the gripping portion during connection to the Luer connector of the medical device;a flexible material disposed over an outer surface of the housing at the tapered portion; andat least one of bumps, ridges, indentations, and protrusions on the outer surface of the gripping portion.
  • 2. The soft grip medical connector of claim 1, wherein the housing further comprises protrusions that are covered by the flexible material, wherein the flexible material is disposed between the protrusions, and wherein the flexible material engages with the protrusions to facilitate retention of the flexible material on the housing.
  • 3. The soft grip medical connector of claim 1, wherein the tapered portion is inwardly tapered to a smaller-width region, and wherein the tapered portion is outwardly tapered from the smaller-width region toward the downstream end to a larger-width region.
  • 4. The soft grip medical connector of claim 1, wherein the at least one of bumps, ridges, indentations, and protrusions include the flexible material and are disposed on an outer surface of the flexible material.
  • 5. The soft grip medical connector of claim 1, wherein the connector is configured to provide a fluid flow rate of at least 600 cubic centimeters per minute through the connector.
  • 6. The soft grip medical connector of claim 1, further comprising a valve member, the valve member having a closed state configured to impede flow of fluid through the connector, and the valve member having an open state configured to permit fluid flow through the connector.
  • 7. The soft grip medical connector of claim 1, wherein the flexible material surrounds an entire circumference of the housing at the gripping portion.
  • 8. The soft grip medical connector of claim 1, wherein the flexible material comprises one or more of silicone rubber, synthetic polyisoprene, and urethane formulations.
  • 9. A soft grip medical connector comprising: a rigid housing comprising:an upstream end;a downstream end;a fluid pathway between the upstream end and the downstream end; andprotrusions on an outer surface of the housing that extend laterally away from a longitudinal axis of the housing, wherein the protrusions include a first protrusion, a second protrusion, and a third protrusion;a flexible member disposed over the outer surface of the housing, the flexible member comprising: a gripping portion; andfirst flexible material disposed between the first protrusion and the second protrusion and second flexible material disposed between the second protrusion and the third protrusion, wherein the flexible material engages with the first, second, and third protrusions to facilitate retention of the flexible member on the housing;wherein the flexible member covers the protrusions.
  • 10. The soft grip medical connector of claim 9, wherein the housing comprises additional protrusions, wherein the flexible member comprises openings in the flexible material, wherein the additional protrusions of the housing extend through the respective openings in the flexible material such that the additional protrusions of the housing extend beyond an outer surface of the flexible member adjacent the openings.
  • 11. The soft grip medical connector of claim 9, wherein the gripping portion comprises: a smaller-width region configured to be grasped between a thumb and finger, the connector having a first lateral width at the smaller-width region;an upper larger-width region between the upstream end and the smaller-width region, the connector having a second lateral width at the upper larger-width region that is larger than the first lateral width; anda lower larger-width region between the downstream end and the smaller-width region, the connector having a third lateral width at the lower larger-width region that is larger than the first lateral width, wherein the upper and lower larger-width regions are configured to impede the thumb and finger from sliding along the connector.
  • 12. The soft grip medical connector of claim 9, wherein an outer surface of the gripping portion has one or more of bumps, ridges, indentations, and protrusions.
  • 13. The soft grip medical connector of claim 9, wherein the connector is configured to provide a fluid flow rate of at least 600 cubic centimeters per minute through the connector.
  • 14. The soft grip medical connector of claim 9, wherein the flexible material surrounds an entire circumference of the housing at the gripping portion.
  • 15. The soft grip medical connector of claim 9, further comprising a valve member, the valve member having a closed state configured to impede flow of fluid through the connector, and the valve member having an open state configured to permit fluid flow through the connector.
  • 16. The soft grip medical connector of claim 9, wherein the housing protrusions comprise a plurality of flanges that extend laterally and are oriented parallel to the longitudinal axis.
  • 17. The soft grip medical connector of claim 9, wherein the protrusions comprise rings that extend circumferentially around at least a portion of the housing.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/887,777, filed Feb. 2, 2018, which is a continuation of U.S. patent application Ser. No. 15/235,683, filed Aug. 12, 2016, which is a continuation of U.S. patent application Ser. No. 14/939,895, filed Nov. 12, 2015, which is a continuation of U.S. patent application Ser. No. 14/268,489, filed May 2, 2014, which is a continuation of U.S. patent application Ser. No. 13/205,463, filed Aug. 8, 2011, which is a continuation of U.S. patent application Ser. No. 12/917,412, filed Nov. 1, 2010, which is a continuation of U.S. patent application Ser. No. 11/417,675, filed May 3, 2006, which is a continuation of U.S. patent application Ser. No. 11/267,822, filed Nov. 4, 2005, which claims the benefit of U.S. Provisional Application No. 60/625,644, filed on Nov. 5, 2004, and U.S. Provisional Application No. 60/654,250, filed on Feb. 18, 2005, the entireties of which are hereby incorporated by reference and made a part of this specification for all that they disclose.

US Referenced Citations (843)
Number Name Date Kind
274447 Kennish Mar 1883 A
1578517 Hein Mar 1926 A
1923501 Perry Aug 1933 A
2210098 Ravenscroft Aug 1940 A
2289677 Perelson Jul 1942 A
2347988 Burke Oct 1943 A
2577780 Lockhart Dec 1951 A
2688979 Kendrick Sep 1954 A
2756282 Deane Jul 1956 A
2756740 Deane Jul 1956 A
2809665 Crowe Oct 1957 A
2847995 Adams Aug 1958 A
2999499 Willet Sep 1961 A
3134380 Armao May 1964 A
3135261 Carroll Jun 1964 A
3171412 Braun Mar 1965 A
3176021 Volungis et al. Mar 1965 A
3191655 McCord Jun 1965 A
3193154 Bross et al. Jul 1965 A
3334860 Bolton, Jr. Aug 1967 A
3352531 Kilmarx Nov 1967 A
3354881 Bloch Nov 1967 A
3385301 Harautuneian May 1968 A
3502097 Muller Mar 1970 A
3534771 Eyerdam et al. Oct 1970 A
3570484 Steer et al. Mar 1971 A
3630199 Gangarosa Dec 1971 A
3648684 Barnwell et al. Mar 1972 A
3659602 Cloyd May 1972 A
3717174 Dewall Feb 1973 A
3726282 Patel Apr 1973 A
3788519 Mengel Jan 1974 A
3830241 Dye et al. Aug 1974 A
3831629 Mackal et al. Aug 1974 A
3852385 Huggins Dec 1974 A
3861388 Vaughn Jan 1975 A
3889675 Stewart Jun 1975 A
3896853 Bernhard Jul 1975 A
3965910 Fisher Jun 1976 A
3974832 Kruck Aug 1976 A
3976063 Henneman et al. Aug 1976 A
3976073 Quick et al. Aug 1976 A
3977403 Patel Aug 1976 A
3986508 Barrington Oct 1976 A
3993063 Larrabee Nov 1976 A
3994293 Ferro Nov 1976 A
4005710 Zeddies et al. Feb 1977 A
4019512 Tenczar Apr 1977 A
4022205 Tenczar May 1977 A
4040420 Speer Aug 1977 A
4076285 Martinez Feb 1978 A
4079738 Dunn et al. Mar 1978 A
4080965 Phillips Mar 1978 A
4121585 Becker, Jr. Oct 1978 A
4128098 Bloom et al. Dec 1978 A
4133441 Mittleman et al. Jan 1979 A
4143853 Abramson Mar 1979 A
4149535 Volder Apr 1979 A
4161949 Thanawalla Jul 1979 A
4186775 Muroi Feb 1980 A
4187846 Lolachi et al. Feb 1980 A
4191183 Mendelson Mar 1980 A
4198983 Becker et al. Apr 1980 A
4200096 Charvin Apr 1980 A
4214779 Losell Jul 1980 A
4219912 Adams Sep 1980 A
4243034 Brandt Jan 1981 A
4257416 Prager Mar 1981 A
D259278 McCaw et al. May 1981 S
4294249 Sheehan et al. Oct 1981 A
4294250 Dennehey Oct 1981 A
4296949 Muetterties et al. Oct 1981 A
4306705 Svensson Dec 1981 A
4324239 Gordon et al. Apr 1982 A
4328802 Curley et al. May 1982 A
4329987 Rogers et al. May 1982 A
4334551 Pfister Jun 1982 A
4338933 Bayard et al. Jul 1982 A
4342315 Jackson Aug 1982 A
4346703 Dennehey et al. Aug 1982 A
4362156 Feller et al. Dec 1982 A
4387879 Tauschinski Jun 1983 A
RE31315 Jenkins et al. Jul 1983 E
4392851 Elias Jul 1983 A
4405163 Voges et al. Sep 1983 A
4405312 Gross et al. Sep 1983 A
4411662 Pearson Oct 1983 A
4417890 Dennehey et al. Nov 1983 A
4421296 Stephens Dec 1983 A
4429856 Jackson Feb 1984 A
4432759 Gross et al. Feb 1984 A
4432765 Oscarsson Feb 1984 A
4434810 Atkinson Mar 1984 A
4439188 Dennehey et al. Mar 1984 A
4439193 Larkin Mar 1984 A
4449693 Gerea May 1984 A
4457749 Bellotti et al. Jul 1984 A
4483368 Panthafer Nov 1984 A
4508367 Oreopoulos et al. Apr 1985 A
4511359 Vaillancourt Apr 1985 A
4512766 Vaillancourt Apr 1985 A
4535818 Duncan et al. Aug 1985 A
4564054 Gustavsson Jan 1986 A
4592356 Guiterrez Jun 1986 A
4607868 Harvey et al. Aug 1986 A
4610469 Wolff-Mooij Sep 1986 A
4617012 Vaillancourt Oct 1986 A
4619640 Poholshy et al. Oct 1986 A
4621654 Holter Nov 1986 A
4623068 Brown et al. Nov 1986 A
4645494 Lee Feb 1987 A
4666429 Stone May 1987 A
4673400 Martin Jun 1987 A
4676228 Krasner et al. Jun 1987 A
4683916 Raines Aug 1987 A
4706487 Bandou et al. Nov 1987 A
4710168 Schwab et al. Dec 1987 A
4725267 Vaillancourt Feb 1988 A
4730635 Linden Mar 1988 A
4752292 Lopez et al. Jun 1988 A
D296592 Wellenstam Jul 1988 S
4758224 Siposs Jul 1988 A
4759756 Forman et al. Jul 1988 A
4775369 Schwartz Oct 1988 A
4778447 Velde et al. Oct 1988 A
4778453 Lopez Oct 1988 A
4781702 Herrli Nov 1988 A
4804015 Albinsson Feb 1989 A
D300177 Bellotti et al. Mar 1989 S
4810241 Rogers et al. Mar 1989 A
4813938 Raulerson Mar 1989 A
4819684 Zaugg et al. Apr 1989 A
4832214 Schrader et al. May 1989 A
4834664 Lin May 1989 A
4834716 Ogle, II May 1989 A
D303013 Konopka Aug 1989 S
4874377 Newgard et al. Oct 1989 A
4878897 Katzin Nov 1989 A
4880414 Whipple Nov 1989 A
4883456 Holter Nov 1989 A
4889527 Herrli Dec 1989 A
4915687 Sivert Apr 1990 A
4917668 Haindl Apr 1990 A
4919167 Manska Apr 1990 A
4928212 Benavides May 1990 A
4934657 Dodson Jun 1990 A
4943896 Johnson Jul 1990 A
4946445 Lynn Aug 1990 A
4963133 Whipple Oct 1990 A
4964855 Todd et al. Oct 1990 A
4966199 Ruschke Oct 1990 A
4969883 Gilbert et al. Nov 1990 A
D314050 Sone Jan 1991 S
4985399 Matsuda et al. Jan 1991 A
4987181 Bichon et al. Jan 1991 A
4991413 Arnalda Feb 1991 A
4991629 Ernesto et al. Feb 1991 A
4991745 Brown Feb 1991 A
4995863 Nichols et al. Feb 1991 A
4998713 Vaillancourt Mar 1991 A
4998927 Vaillancourt Mar 1991 A
5006114 Rogers et al. Apr 1991 A
5009490 Kuono et al. Apr 1991 A
5018532 Ethridge, III May 1991 A
5024657 Needham et al. Jun 1991 A
5030210 Alchas Jul 1991 A
5031675 Lindqren Jul 1991 A
5041087 Loo et al. Aug 1991 A
5046456 Heyman et al. Sep 1991 A
5049128 Duquette Sep 1991 A
D321250 Jepson et al. Oct 1991 S
D321251 Jepson et al. Oct 1991 S
5061253 Yoshida Oct 1991 A
5064416 Newgard Nov 1991 A
5065783 Ogle, II Nov 1991 A
5071411 Hillstead Dec 1991 A
5098385 Walsh Mar 1992 A
5098405 Peterson et al. Mar 1992 A
5098406 Sawyer Mar 1992 A
5100394 Dudar et al. Mar 1992 A
5108380 Heritze et al. Apr 1992 A
5114408 Fleischhaker et al. May 1992 A
5116361 Kim et al. May 1992 A
5122123 Vaillancourt Jun 1992 A
5125915 Berry et al. Jun 1992 A
5135489 Jepson et al. Aug 1992 A
5137524 Lynn et al. Aug 1992 A
5147333 Raines Sep 1992 A
5154703 Bonaldo Oct 1992 A
5156600 Young Oct 1992 A
5158554 Jepson et al. Oct 1992 A
5163922 McElveen, Jr. et al. Nov 1992 A
5167238 Newman Dec 1992 A
5167636 Clement Dec 1992 A
5171234 Jepson et al. Dec 1992 A
5180761 Shiao Jan 1993 A
5188620 Jepson et al. Feb 1993 A
5190067 Paradis et al. Mar 1993 A
5199947 Lopez et al. Apr 1993 A
5201717 Wyatt et al. Apr 1993 A
5201722 Moorehead et al. Apr 1993 A
5203775 Frank et al. Apr 1993 A
5211638 Dudar et al. May 1993 A
5215538 Larkin Jun 1993 A
5221271 Nicholson et al. Jun 1993 A
5224515 Foster et al. Jul 1993 A
5242393 Brimhall et al. Sep 1993 A
5242423 Goodsir et al. Sep 1993 A
5242425 Whine et al. Sep 1993 A
5242432 DeFrank Sep 1993 A
5249598 Schmidt Oct 1993 A
5251873 Atkinson et al. Oct 1993 A
5253842 Huebscher et al. Oct 1993 A
5255676 Russo Oct 1993 A
5256155 Yerlikaya et al. Oct 1993 A
5267966 Paul Dec 1993 A
5269771 Thomas et al. Dec 1993 A
5273533 Bonaldo Dec 1993 A
5280876 Atkins Jan 1994 A
5284475 Mackal Feb 1994 A
5290254 Vaillancourt Mar 1994 A
5292308 Ryan Mar 1994 A
5293902 Lapierie Mar 1994 A
5295657 Atkinson Mar 1994 A
5295658 Atkinson et al. Mar 1994 A
5301686 Newman Apr 1994 A
5306265 Ragazzi Apr 1994 A
5312083 Ekman May 1994 A
5312377 Dalhon May 1994 A
5322518 Schneider Jun 1994 A
5324270 Kayon et al. Jun 1994 A
5336192 Palestrant Aug 1994 A
5342316 Wallace Aug 1994 A
5342326 Peppel et al. Aug 1994 A
5344414 Lopez et al. Sep 1994 A
5348542 Ellis Sep 1994 A
5353837 Faust Oct 1994 A
5356396 Wyatt et al. Oct 1994 A
5360413 Leason et al. Nov 1994 A
5380306 Brinon Jan 1995 A
5389086 Attermeier et al. Feb 1995 A
5398530 Derman Mar 1995 A
5401245 Haining Mar 1995 A
5402826 Molnar et al. Apr 1995 A
5402982 Atkinson et al. Apr 1995 A
5407437 Heimreid Apr 1995 A
5409471 Atkinson et al. Apr 1995 A
5395348 Ryan May 1995 A
5411483 Loomas et al. May 1995 A
5411499 Dudar et al. May 1995 A
5417673 Gordon May 1995 A
5439451 Collinson et al. Aug 1995 A
5439452 McCarty Aug 1995 A
5441487 Vedder Aug 1995 A
5442941 Kahonan et al. Aug 1995 A
5456676 Nelson Oct 1995 A
5462255 Rosen et al. Oct 1995 A
5470319 Mayer Nov 1995 A
5474544 Lynn Dec 1995 A
5480393 Bommarito Jan 1996 A
5487731 Denton Jan 1996 A
5501426 Atkinson Mar 1996 A
5501526 Asai et al. Mar 1996 A
5509433 Paradis Apr 1996 A
5514116 Vaillancourt et al. May 1996 A
5520665 Fleetwood May 1996 A
5522804 Lynn Jun 1996 A
5533708 Atkinson et al. Jul 1996 A
5533996 Murphey et al. Jul 1996 A
5535771 Purdy et al. Jul 1996 A
5535785 Werge et al. Jul 1996 A
5540661 Tomisaka et al. Jul 1996 A
5549566 Elias et al. Aug 1996 A
5549577 Siegel et al. Aug 1996 A
5549651 Lynn Aug 1996 A
5554136 Luther Sep 1996 A
5555908 Edwards et al. Sep 1996 A
5556388 Johlin, Jr. Sep 1996 A
5562632 Davila et al. Oct 1996 A
5569235 Ross et al. Oct 1996 A
5573516 Tyner Nov 1996 A
5577706 King Nov 1996 A
5578059 Patzer Nov 1996 A
5597536 Mayer Jan 1997 A
5674206 Allton et al. Jan 1997 A
5603706 Wyatt et al. Feb 1997 A
5609584 Gettig et al. Mar 1997 A
5616129 Mayer Apr 1997 A
5616130 Mayer Apr 1997 A
5617897 Myers Apr 1997 A
5620424 Abramson Apr 1997 A
5620434 Brony Apr 1997 A
5624414 Boettger Apr 1997 A
5632735 Wyatt et al. May 1997 A
5639810 Smith, III et al. Jun 1997 A
5660205 Epstein Aug 1997 A
5667500 Palmer et al. Sep 1997 A
5669891 Vaillancourt Sep 1997 A
5676346 Leinsing Oct 1997 A
5685866 Lopez Nov 1997 A
5690612 Lopez et al. Nov 1997 A
5690865 Kindt-Larsen et al. Nov 1997 A
5694686 Lopez Dec 1997 A
5695466 Lopez et al. Dec 1997 A
5699821 Paradis Dec 1997 A
5700248 Lopez Dec 1997 A
5707357 Mikhail et al. Jan 1998 A
5728751 Patnaik Mar 1998 A
5730418 Feith et al. Mar 1998 A
5738663 Lopez Apr 1998 A
5749861 Guala et al. May 1998 A
5769825 Lynn Jun 1998 A
5775671 Cote, Sr. Jul 1998 A
5776113 Daugherty et al. Jul 1998 A
5782816 Werschmidt Jul 1998 A
5785693 Haining Jul 1998 A
5788215 Ryan Aug 1998 A
5797897 Jepson et al. Aug 1998 A
5806551 Meloul et al. Sep 1998 A
5806831 Paradis Sep 1998 A
5807348 Zinger et al. Sep 1998 A
5807349 Person et al. Sep 1998 A
5810789 Powers et al. Sep 1998 A
5817069 Arnett Oct 1998 A
5820601 Mayer Oct 1998 A
5833213 Ryan Nov 1998 A
5836923 Mayer Nov 1998 A
5839715 Leinsing Nov 1998 A
5843044 Moorehead Dec 1998 A
5843046 Motisi et al. Dec 1998 A
5846233 Lilley et al. Dec 1998 A
5865807 Blake, III Feb 1999 A
5873862 Lopez Feb 1999 A
5882348 Winterton et al. Mar 1999 A
5899888 Jepson et al. May 1999 A
5901942 Lopez May 1999 A
5911710 Barry et al. Jun 1999 A
5928204 Lopez Jul 1999 A
5935620 Baudin Aug 1999 A
5947954 Bonaldo Sep 1999 A
5954313 Ryan Sep 1999 A
5957898 Jepson et al. Sep 1999 A
5967490 Pike Oct 1999 A
5979868 Wu et al. Nov 1999 A
5984903 Nadal Nov 1999 A
6009902 Troiani et al. Jan 2000 A
6019748 Lopez Feb 2000 A
6029946 Doyle Feb 2000 A
6036171 Weinheimer et al. Mar 2000 A
6039302 Cote, Sr. et al. Mar 2000 A
6048335 Mayer Apr 2000 A
6050978 Orr et al. Apr 2000 A
6063062 Paradis May 2000 A
6079432 Paradis Jun 2000 A
6089541 Weinheier et al. Jul 2000 A
6113068 Ryan Sep 2000 A
6116571 Hettinger Sep 2000 A
6117114 Paradis Sep 2000 A
6132403 Lopez Oct 2000 A
6132404 Lopez Oct 2000 A
6142446 Leinsing Nov 2000 A
6152900 Mayer Nov 2000 A
6162206 Bindokas et al. Dec 2000 A
6162251 Kredovski Dec 2000 A
6168137 Paradis Jan 2001 B1
6170800 Meloul et al. Jan 2001 B1
6171287 Lynn Jan 2001 B1
6177037 Mayer Jan 2001 B1
6183448 Mayer Feb 2001 B1
6189859 Rohrbough et al. Feb 2001 B1
6206861 Mayer Mar 2001 B1
6210624 Mayer Apr 2001 B1
6213996 Jepson et al. Apr 2001 B1
6228065 Lynn May 2001 B1
6228069 Barth et al. May 2001 B1
6245048 Fangrow et al. Jun 2001 B1
6254579 Cogger et al. Jul 2001 B1
6261282 Jepson et al. Jul 2001 B1
6261630 Nazarova et al. Jul 2001 B1
6279783 Brown et al. Aug 2001 B1
6290206 Doyle Sep 2001 B1
6299131 Ryan Oct 2001 B1
6299132 Wienheimer Oct 2001 B1
6325782 Lopez Dec 2001 B1
6364869 Bonaldo Apr 2002 B1
6428520 Lopez et al. Aug 2002 B1
6444324 Yang et al. Sep 2002 B1
6482188 Rogers et al. Nov 2002 B1
D468016 Mosler et al. Dec 2002 S
6530504 Socier Mar 2003 B2
6541802 Doyle Apr 2003 B2
6543745 Enerson Apr 2003 B1
6572592 Lopez Jun 2003 B1
D476731 Cise et al. Jul 2003 S
6585229 Cote, Sr. et al. Jul 2003 B2
6595964 Finley et al. Jul 2003 B2
6595981 Huet Jul 2003 B2
6599273 Lopez Jul 2003 B1
6605076 Jepson et al. Aug 2003 B1
6609696 Enerson Aug 2003 B2
6635044 Lopez Oct 2003 B2
6651956 Miller Nov 2003 B2
6656517 Michal et al. Dec 2003 B2
6669673 Lopez Dec 2003 B2
6669681 Jepson et al. Dec 2003 B2
6673053 Wang et al. Jan 2004 B2
6682509 Lopez Jan 2004 B2
6689109 Lynn Feb 2004 B2
6695817 Fangrow, Jr. Feb 2004 B1
6706022 Leinsing et al. Mar 2004 B1
6712791 Lui et al. Mar 2004 B2
6727294 Kanayama et al. Apr 2004 B2
6740063 Lynn May 2004 B2
6745998 Doyle Jun 2004 B2
6755391 Newton et al. Jun 2004 B2
6758833 Lopez Jul 2004 B2
6783709 Harreld et al. Aug 2004 B2
6802490 Leinsing Oct 2004 B2
6808161 Hishikawa Oct 2004 B1
6832994 Niedospial, Jr. et al. Dec 2004 B2
6840501 Doyle Jan 2005 B2
6848139 Simon et al. Feb 2005 B2
6866656 Tingey et al. Mar 2005 B2
6869426 Ganem Mar 2005 B2
6871838 Raines et al. Mar 2005 B2
6883778 Newton et al. Apr 2005 B1
6892998 Newton May 2005 B2
6908459 Harding et al. Jun 2005 B2
6916309 Fangrow, Jr. Jul 2005 B2
6932795 Lopez et al. Aug 2005 B2
6964406 Doyle Nov 2005 B2
6991215 Kiehne Jan 2006 B2
6994315 Ryan et al. Feb 2006 B2
6997917 Niedospial, Jr. et al. Feb 2006 B2
7014169 Newton et al. Mar 2006 B2
7025744 Utterberg et al. Apr 2006 B2
7033339 Lynn Apr 2006 B1
7037302 Vaillancourt May 2006 B2
7044441 Doyle May 2006 B2
7074216 Fowles et al. Jul 2006 B2
7100890 Cote et al. Sep 2006 B2
7104520 Leinsing et al. Sep 2006 B2
7114701 Peppel Oct 2006 B2
7125396 Leinsing et al. Oct 2006 B2
7140592 Phillips et al. Nov 2006 B2
7184825 Leinsing et al. Feb 2007 B2
D547862 Dikeman et al. Jul 2007 S
7244249 Leinsing et al. Jul 2007 B2
7252652 Moorehead et al. Aug 2007 B2
7264859 Souns et al. Sep 2007 B2
7306197 Parrino et al. Dec 2007 B2
7306199 Leinsing et al. Dec 2007 B2
7314061 Peppel Jan 2008 B2
7329249 Bonaldo Feb 2008 B2
7335182 Hilaire Feb 2008 B1
D567941 Dikeman et al. Apr 2008 S
7357792 Newton et al. Apr 2008 B2
D568466 Dikeman et al. May 2008 S
D569506 Dikeman et al. May 2008 S
7396348 Newton et al. Jul 2008 B2
7422369 Bergman et al. Sep 2008 B2
7470261 Lynn Dec 2008 B2
7470262 Hiejima et al. Dec 2008 B2
7497848 Leinsing et al. Mar 2009 B2
7497849 Fangrow, Jr. Mar 2009 B2
7510545 Peppel Mar 2009 B2
7520489 Rushke Apr 2009 B2
7530546 Ryan et al. May 2009 B2
7556060 Guala Jul 2009 B2
7559530 Korogi et al. Jul 2009 B2
7563243 Mendels Jul 2009 B2
7581561 Funamura et al. Sep 2009 B2
7584767 Funamura et al. Sep 2009 B2
7588563 Guala Sep 2009 B2
7591449 Raines et al. Sep 2009 B2
7600530 Truitt et al. Oct 2009 B2
7601141 Dikeman et al. Oct 2009 B2
7615035 Peppel Nov 2009 B2
7624749 Guala Dec 2009 B2
7625359 Guala Dec 2009 B2
7628774 Fangrow, Jr. Dec 2009 B2
7645274 Whitley Jan 2010 B2
7651481 Raybuck Jan 2010 B2
7666170 Guala Feb 2010 B2
7673653 Mijers et al. Mar 2010 B2
7691090 Belley et al. Apr 2010 B2
7703486 Costanzo Apr 2010 B2
7713250 Harding et al. May 2010 B2
7717882 Harding May 2010 B2
7717886 Lopez May 2010 B2
7743799 Mosler et al. Jun 2010 B2
7753338 Desecki Jul 2010 B2
7753892 Newton et al. Jul 2010 B2
7758566 Simpson et al. Jul 2010 B2
7763013 Baldwin et al. Jul 2010 B2
7763199 Fangrow Jul 2010 B2
7771383 Truitt et al. Aug 2010 B2
7784766 Guala Aug 2010 B2
7799009 Niedospial, Jr. et al. Sep 2010 B2
7806873 Dikeman et al. Oct 2010 B2
7815168 Vangsness et al. Oct 2010 B2
7824393 Fangrow, Jr. Nov 2010 B2
7837658 Cote, Sr. et al. Nov 2010 B2
7841581 Thorne, Jr. et al. Nov 2010 B2
7842026 Cahill et al. Nov 2010 B2
7857284 Kimball et al. Dec 2010 B2
7857285 Lee et al. Dec 2010 B2
7857802 Brandenburger et al. Dec 2010 B2
7857805 Raines Dec 2010 B2
7862537 Zinger et al. Jan 2011 B2
7867204 Bartholomew et al. Jan 2011 B2
7879012 Kane et al. Feb 2011 B2
7879013 Smith et al. Feb 2011 B2
7900659 Whitley et al. Mar 2011 B2
7905873 Rondeau et al. Mar 2011 B2
7909056 Truitt et al. Mar 2011 B2
7914502 Newton et al. Mar 2011 B2
7947032 Harding et al. May 2011 B2
7954515 Gerst Jun 2011 B2
7959614 Dikeman et al. Jun 2011 B2
7967797 Winsor et al. Jun 2011 B2
7975722 Kiehne Jul 2011 B2
7981090 Plishka et al. Jul 2011 B2
7981381 Lurvey et al. Jul 2011 B2
7984730 Ziv et al. Jul 2011 B2
7985206 Dikeman et al. Jul 2011 B2
7988128 Wentling Aug 2011 B2
7993328 Whitley Aug 2011 B2
7998122 Lynn et al. Aug 2011 B2
7998134 Fangrow Aug 2011 B2
8006953 Bennett Aug 2011 B2
D644731 Fangrow, Jr. Sep 2011 S
8015990 Pascal et al. Sep 2011 B2
8021354 Huang Sep 2011 B2
8034021 Mendels Oct 2011 B2
8034035 Weaver et al. Oct 2011 B2
8038663 Miner Oct 2011 B2
8042838 Buckler et al. Oct 2011 B2
8048038 Guala Nov 2011 B2
8052648 Dikeman et al. Nov 2011 B2
8057442 Dikeman et al. Nov 2011 B2
8062266 McKinnon et al. Nov 2011 B2
8062267 McKinnon et al. Nov 2011 B2
8062280 Jepson et al. Nov 2011 B2
8066648 Mark Nov 2011 B1
8066669 Christensen et al. Nov 2011 B2
8066670 Cluff et al. Nov 2011 B2
8070189 Yow et al. Dec 2011 B2
8070725 Christensen Dec 2011 B2
8074964 Mansour et al. Dec 2011 B2
8092432 Nordgren Jan 2012 B2
8096525 Ryan Jan 2012 B2
8100868 Newton et al. Jan 2012 B2
8100869 Vangsness et al. Jan 2012 B2
8105314 Fangrow Jan 2012 B2
8122923 Kraus et al. Feb 2012 B2
8123738 Vaillancourt Feb 2012 B2
8133209 Guala Mar 2012 B2
8136330 Ostler et al. Mar 2012 B2
8137303 Stout et al. Mar 2012 B2
8142403 Carlyon Mar 2012 B2
8152790 Lopez et al. Apr 2012 B2
8156971 Costanzo Apr 2012 B2
8157784 Rogers Apr 2012 B2
8162006 Guala Apr 2012 B2
8162013 Rosenquist et al. Apr 2012 B2
8162914 Kraushaar et al. Apr 2012 B2
8167863 Yow May 2012 B2
8172823 Rondeau et al. May 2012 B2
8177760 Rome et al. May 2012 B2
8177768 Leinsing May 2012 B2
8177772 Christensen et al. May 2012 B2
8182452 Mansourt et al. May 2012 B2
8197452 Harding et al. Jun 2012 B2
8197466 Yokota et al. Jun 2012 B2
8211089 Winsor et al. Jul 2012 B2
8221363 Jepson Jul 2012 B2
8221391 Fangrow, Jr. Jul 2012 B2
8241268 Whitley Aug 2012 B2
8277424 Whitley Oct 2012 B2
8286657 Belley et al. Oct 2012 B2
8287518 Kitani et al. Oct 2012 B2
8298195 Peppel Oct 2012 B2
8298196 Mansour Oct 2012 B1
8328769 Dikeman et al. Dec 2012 B2
8337483 Harding et al. Dec 2012 B2
8361408 Lynn Jan 2013 B2
8366658 Davis et al. Feb 2013 B2
8366676 Harding et al. Feb 2013 B2
8372043 Grimm et al. Feb 2013 B2
8377010 Harding et al. Feb 2013 B2
8382741 Chelak Feb 2013 B2
8398598 Carlyon et al. Mar 2013 B2
8398607 Fangrow, Jr. Mar 2013 B2
8403886 Bialecki et al. Mar 2013 B2
8403894 Lynn et al. Mar 2013 B2
8403905 Yow Mar 2013 B2
8408226 Raines et al. Apr 2013 B2
8409164 Fangrow Apr 2013 B2
8409165 Niedospial, Jr. et al. Apr 2013 B2
8414542 Stroup Apr 2013 B2
8439880 Rondeau May 2013 B2
8444628 Fangrow, Jr. May 2013 B2
8454579 Fangrow, Jr. Jun 2013 B2
8511352 Kraus et al. Aug 2013 B2
8512307 Fangrow Aug 2013 B2
8529524 Newton et al. Sep 2013 B2
8540692 Fangrow Sep 2013 B2
8551037 Suchecki et al. Oct 2013 B2
8568371 Siopes et al. Oct 2013 B2
8591476 Winsor et al. Nov 2013 B2
8628515 Fangrow, Jr. et al. Jan 2014 B2
8636720 Truitt et al. Jan 2014 B2
8640725 Truitt et al. Feb 2014 B2
8671964 Py Mar 2014 B2
8679090 Anderson et al. Mar 2014 B2
8684994 Lev et al. Apr 2014 B2
8702675 Imai Apr 2014 B2
8715222 Truitt et al. May 2014 B2
8715247 Mansour et al. May 2014 B2
8721627 Albert May 2014 B2
8758306 Lopez et al. Jun 2014 B2
8808254 Lynn Aug 2014 B2
8814849 Winsor Aug 2014 B1
8834432 Winsor et al. Sep 2014 B2
8864725 Ranalletta et al. Oct 2014 B2
8870846 Davis et al. Oct 2014 B2
8870850 Fangrow, Jr. Oct 2014 B2
8876784 Cote, Sr. et al. Nov 2014 B2
8882742 Dikeman et al. Nov 2014 B2
8910919 Bonnal et al. Dec 2014 B2
8945084 Warren et al. Feb 2015 B2
8951233 Mansour Feb 2015 B2
8968261 Kimball et al. Mar 2015 B2
8974425 Tachizaki et al. Mar 2015 B2
8974433 Fangrow Mar 2015 B2
8992501 Seifert et al. Mar 2015 B2
9005179 Fangrow et al. Apr 2015 B2
9005180 Seifert et al. Apr 2015 B2
9017295 Pan Apr 2015 B2
9039047 Imai May 2015 B2
9044585 Masuda et al. Jun 2015 B2
9060921 Seifert et al. Jun 2015 B2
9061130 Truitt et al. Jun 2015 B2
9067049 Panian et al. Jun 2015 B2
9072657 Seifert et al. Jul 2015 B2
9107809 Garfield et al. Aug 2015 B2
9119950 Mansour et al. Sep 2015 B2
9138572 Zeytoonian et al. Sep 2015 B2
9186494 Fangrow et al. Nov 2015 B2
9192753 Lopez et al. Nov 2015 B2
9198831 Rogers Dec 2015 B2
9205243 Lopez et al. Dec 2015 B2
9220882 Belley et al. Dec 2015 B2
9238129 Fangrow et al. Jan 2016 B2
9259565 Siopes et al. Feb 2016 B2
9278206 Fangrow et al. Mar 2016 B2
9289588 Chen Mar 2016 B2
9314604 Bonnal et al. Apr 2016 B2
9345641 Kraus et al. May 2016 B2
9370466 Garfield et al. Jun 2016 B2
9381339 Wu et al. Jul 2016 B2
9393398 Truitt et al. Jul 2016 B2
9415200 Fangrow Aug 2016 B2
9440060 Fangrow Sep 2016 B2
9533137 Fangrow Jan 2017 B2
9579495 Tachizaki Feb 2017 B2
9750926 Lopez et al. Sep 2017 B2
9884176 Fangrow et al. Feb 2018 B2
10071852 Stewart et al. Sep 2018 B2
10086188 Fangrow Oct 2018 B2
10173045 Mansour et al. Jan 2019 B2
10195413 Lopez et al. Feb 2019 B2
10391293 Fangrow Aug 2019 B2
10688293 Ueda et al. Jun 2020 B2
10722698 Fangrow Jul 2020 B2
10799692 Fangrow Oct 2020 B2
11071852 Lopez et al. Jul 2021 B2
11376411 Fangrow Jul 2022 B2
20010049508 Fangrow, Jr. Dec 2001 A1
20020024036 Rohrbough et al. Feb 2002 A1
20020120333 Keogh et al. Aug 2002 A1
20020156430 Haarala et al. Oct 2002 A1
20040006330 Fangrow, Jr. Jan 2004 A1
20040201216 Segal et al. Oct 2004 A1
20050010176 Dikeman et al. Jan 2005 A1
20050020981 Kurth Jan 2005 A1
20050059952 Giuliano et al. Mar 2005 A1
20050121638 Doyle Jun 2005 A1
20050222541 Lopez et al. Oct 2005 A1
20050234405 Dikeman et al. Oct 2005 A1
20060004331 Fangrow, Jr. Jan 2006 A1
20060161115 Fangrow, Jr. Jul 2006 A1
20060200088 Lopez Sep 2006 A1
20060200089 Lopez et al. Sep 2006 A1
20060200090 Lopez et al. Sep 2006 A1
20060206061 Lopez et al. Sep 2006 A1
20060211997 Fangrow, Jr. Sep 2006 A1
20060211998 Fangrow, Jr. Sep 2006 A1
20060211999 Fangrow, Jr. Sep 2006 A1
20060212001 Fangrow, Jr. Sep 2006 A1
20060212003 Fangrow, Jr. Sep 2006 A1
20060212006 Fangrow, Jr. Sep 2006 A1
20060224127 Fangrow, Jr. Oct 2006 A1
20060264842 Fangrow, Jr. Nov 2006 A1
20060264844 Fangrow, Jr. Nov 2006 A1
20060264849 Lopez et al. Nov 2006 A1
20060264909 Fangrow, Jr. Nov 2006 A1
20060264910 Fangrow, Jr. Nov 2006 A1
20060270999 Fangrow, Jr. Nov 2006 A1
20060271016 Fangrow, Jr. Nov 2006 A1
20060276757 Fangrow, Jr. Dec 2006 A1
20060276758 Fangrow, Jr. Dec 2006 A1
20070100284 Leinsing et al. May 2007 A1
20070106205 Connell et al. May 2007 A1
20070112312 Fangrow, Jr. May 2007 A1
20070112313 Fangrow, Jr. May 2007 A1
20070224865 Fangrow, Jr. Sep 2007 A1
20070225425 Nash et al. Sep 2007 A1
20070235676 Vangsness et al. Oct 2007 A1
20070254000 Guo et al. Nov 2007 A1
20070270756 Peppel et al. Nov 2007 A1
20080039802 Vangsness et al. Feb 2008 A1
20080086095 Dikeman et al. Apr 2008 A1
20080086097 Rasmussen et al. Apr 2008 A1
20080086099 McKinnon et al. Apr 2008 A1
20080097407 Plishka Apr 2008 A1
20080169444 Guala Jul 2008 A1
20080249508 Lopez et al. Oct 2008 A1
20090005761 Guala Jan 2009 A1
20090209922 Boisjoly Aug 2009 A1
20090292252 Lareau et al. Nov 2009 A1
20090292274 Guala Nov 2009 A1
20100030163 Carrez et al. Feb 2010 A1
20100030164 Kimball et al. Feb 2010 A1
20100036330 Plishka et al. Feb 2010 A1
20100059474 Brandenburger et al. Mar 2010 A1
20100059702 Mansour et al. Mar 2010 A1
20100063456 Rahimy et al. Mar 2010 A1
20100063482 Mansour Mar 2010 A1
20100108681 Jepson et al. May 2010 A1
20100152680 Memahon Jun 2010 A1
20100174242 Anderson et al. Jul 2010 A1
20100179514 Guala Jul 2010 A1
20100241088 Ranalletta et al. Sep 2010 A1
20100249723 Fangrow, Jr. Sep 2010 A1
20100249724 Cote, Sr. et al. Sep 2010 A1
20100249725 Cote, Sr. et al. Sep 2010 A1
20100264343 Jeory Oct 2010 A1
20100270792 Lauer Oct 2010 A1
20100283238 Deighan et al. Nov 2010 A1
20100292673 Korogi et al. Nov 2010 A1
20100292674 Jepson et al. Nov 2010 A1
20100300556 Carmody et al. Dec 2010 A1
20100324502 Guala Dec 2010 A1
20110004183 Carrez et al. Jan 2011 A1
20110024664 Burnard et al. Feb 2011 A1
20110028914 Mansour et al. Feb 2011 A1
20110046572 Fangrow Feb 2011 A1
20110028915 Siopes et al. Mar 2011 A1
20110048540 Stroup Mar 2011 A1
20110054440 Lewis Mar 2011 A1
20110060293 Guala Mar 2011 A1
20110087164 Mosler et al. Apr 2011 A1
20110106046 Hiranuma et al. May 2011 A1
20110130717 David et al. Jun 2011 A1
20110130724 Mansour et al. Jun 2011 A1
20110130726 Crawford et al. Jun 2011 A1
20110130727 Crawford et al. Jun 2011 A1
20110130728 McKinnon Jun 2011 A1
20110152832 Foshee et al. Jun 2011 A1
20110166532 Brandenburger et al. Jul 2011 A1
20110178493 Okiyama Jul 2011 A1
20110257590 Winsor et al. Oct 2011 A1
20110264037 Foshee et al. Oct 2011 A1
20110266477 Stroup Nov 2011 A1
20110275988 Davis et al. Nov 2011 A1
20110276010 Davis et al. Nov 2011 A1
20110276031 Hoang et al. Nov 2011 A1
20110295235 Fangrow Dec 2011 A1
20110306940 Miyasaka Dec 2011 A1
20110319821 Kitani et al. Dec 2011 A1
20110319859 Zeytoonian et al. Dec 2011 A1
20120013121 Weckstrom Jan 2012 A1
20120022469 Alpert Jan 2012 A1
20120042971 Py Feb 2012 A1
20120046636 Kriheli Feb 2012 A1
20120053529 Imai Mar 2012 A1
20120059314 Eichhorst Mar 2012 A1
20120059334 Pan Mar 2012 A1
20120059346 Sheppard et al. Mar 2012 A1
20120095407 Chebator et al. Apr 2012 A1
20120109077 Ryan May 2012 A1
20120150129 Jin et al. Jun 2012 A1
20120153201 Larose et al. Jun 2012 A1
20120157928 Mermet Jun 2012 A1
20120157933 Newton et al. Jun 2012 A1
20120179108 Delabie Jul 2012 A1
20120209238 Rosenquist et al. Aug 2012 A1
20120215182 Mansour et al. Aug 2012 A1
20120220955 Maseda et al. Aug 2012 A1
20120220977 Yow Aug 2012 A1
20120220984 Christensen et al. Aug 2012 A1
20120245564 Tekeste et al. Sep 2012 A1
20120259292 Koehler Oct 2012 A1
20120316514 Mansour Dec 2012 A1
20120316536 Carrez et al. Dec 2012 A1
20120323063 Costanzo Dec 2012 A1
20130030386 Panian et al. Jan 2013 A1
20130035668 Kitani et al. Feb 2013 A1
20130046315 Woehr et al. Feb 2013 A1
20130053815 Mucientes et al. Feb 2013 A1
20130060205 Mansour et al. Mar 2013 A1
20130066293 Garfield et al. Mar 2013 A1
20130079730 Mosler et al. Mar 2013 A1
20130138075 Lambert May 2013 A1
20130331800 Newton et al. Dec 2013 A1
20140174578 Bonnal et al. Jun 2014 A1
20140209197 Carrez et al. Jul 2014 A1
20140257198 Truitt et al. Sep 2014 A1
20140316350 Yamaguchi et al. Oct 2014 A1
20140358033 Lynn Dec 2014 A1
20140371686 Sano et al. Dec 2014 A1
20150008664 Tachizaki Jan 2015 A1
20150148756 Lynn May 2015 A1
20150151100 Mansour Jun 2015 A1
20150190627 Ueda et al. Jul 2015 A1
20150196749 Ziv et al. Jul 2015 A1
20150265829 Truitt et al. Sep 2015 A1
20150320992 Bonnet et al. Nov 2015 A1
20160106970 Fangrow Apr 2016 A1
20160114147 Siopes et al. Apr 2016 A1
20160199575 Belley et al. Jul 2016 A1
20160263369 Naftalovitz et al. Sep 2016 A1
20160317798 Lopez Nov 2016 A1
20180289942 Fangrow Jan 2018 A1
20180050184 Lopez Feb 2018 A1
20180099137 Fangrow Apr 2018 A1
20190001114 Fangrow Jan 2019 A1
20190269900 Fangrow Sep 2019 A1
20190314624 Yeh Oct 2019 A1
20190358443 Lopez Nov 2019 A1
20210093850 Fangrow Apr 2021 A1
Foreign Referenced Citations (51)
Number Date Country
1 105 959 Jul 1981 CA
2 149 725 Nov 1995 CA
2 175 021 Nov 1996 CA
2 476 075 Oct 2003 CA
636526 Jun 1983 CH
670955 Jul 1989 CH
855 319 Sep 1952 DE
84 25 197.2 Sep 1985 DE
37 40 269 Jun 1989 DE
0 263 789 Apr 1988 EP
0 309 771 Apr 1989 EP
0 399 119 Nov 1990 EP
0 446 463 Sep 1991 EP
0 805 930 Jun 2002 EP
1 466 644 Oct 2004 EP
1 547 646 Jun 2005 EP
1 563 867 Aug 2005 EP
1 854 502 Nov 2007 EP
1 857 137 Nov 2007 EP
1 669 101 Jul 2008 EP
2 004 274 Dec 2008 EP
2 679 274 Jan 2014 EP
2 707 505 Jan 1995 FR
2 000 685 Jan 1979 GB
2 001 146 Jan 1979 GB
2 034 185 Jun 1980 GB
2009-039513 Feb 2009 JP
102370973 Mar 2022 KR
333508 Aug 2005 NZ
WO 199220736 Nov 1992 WO
WO 199422523 Oct 1994 WO
WO 199623158 Jan 1996 WO
WO 199959672 Nov 1999 WO
WO 199961093 Dec 1999 WO
WO 200020070 Apr 2000 WO
WO 2003018104 Mar 2003 WO
WO 2005115521 Aug 2005 WO
WO 2006013433 Feb 2006 WO
WO 2006062912 Jun 2006 WO
WO 2007033103 Mar 2007 WO
WO 2007103998 Sep 2007 WO
WO 2007112278 Oct 2007 WO
WO 2008048777 Apr 2008 WO
WO 2008062741 May 2008 WO
WO 2009052433 Apr 2009 WO
WO 2009111596 Sep 2009 WO
WO 2010135080 Nov 2010 WO
WO 2011064738 Jun 2011 WO
WO 2011101389 Aug 2011 WO
WO 2011104711 Sep 2011 WO
WO 2018236846 Dec 2018 WO
Non-Patent Literature Citations (24)
Entry
Reexamination proceedings for U.S. Pat. No. 5,730,418 (Reexamination Control No. 90/006,117) including the amendments filed by the owner of the patent during reexamination proceedings.
U.S. Appl. No. 14/996,564, filed Jan. 15, 2016, Fangrow.
U.S. Appl. No. 15/693,853, filed Sep. 1, 2017, Lopez et al.
U.S. Appl. No. 08/767,587, filed Dec. 16, 1996, Lopez et al.
U.S. Appl. No. 10/217,213, filed Aug. 9, 2002, Fangrow et al.
International Search Report and Written Opinion for PCT/US2005039791, dated May 4, 2006.
International Search Report and Written Opinion for PCT/US07/04347, dated Oct. 26, 2007.
Extended Search Report for Application No. 08014856.2 dated Jan. 26, 2009.
CardinalHealth, SmartSite Brochure: “SmartSite® Disposables,” 2004, in 12 pages.
“Faulding Inc. receives FDA permission to market patented Safe-Connect Valve”, dated Dec. 2, 1996.
BD Medical: Needleless IV Access Devices, one page, 2007.
Capless Backcheck Valve, dated Sep. 3, 1993.
CareFusion, Medegen Introduces MaxPlus® Clear, First and Only Clear Positive Displacement Connector for Use in Infusion Therapy, MaxGuard News, one page article, dated Mar. 10, 2008—Ontario, CA.
Caresite™ Luer Access Device, dated 2010.
Clearlink, needleless IV access system, Baxter 2007 brochure in 2 pages.
F.D.A. 510(k) Summary of Safety and Effectiveness, dated Nov. 17, 1997.
LifeShield TKO Anti-Reflux Device Brochure, appears to contain a date of Feb. 8.
MEDI-4955 Liquid Silicone Rubber from NuSil Silicone Technology, dated Dec. 17, 2010.
MicroClave Connector Brochure. The MicroClave was available before Mar. 25, 2008.
MicroClave Neutral Displacement Connector A Neddlefree Closed System Device. Brochure Sep. 24, 2008.
MicroClave Product Page Video Shots. Sep. 24, 2008.
PASV Valve Connector Brochure, which appears to be at least as early as Feb. 20, 2001.
Photographs of LifeShield CLAVE®& TKO-4S product, consisting of a needleless valve essentially as illustrated in Lopez (U.S. Pat. No. 5,685,866) and a flow control valve essentially as illustrated in Dikeman (U.S. Pat. No. 7,601,141), sold in the U.S. at least as early as May 2008.
Saechtling Tworzywa Sztuczne, WN-T Warszawa, 1999, V edition, pp. 224-225.
Related Publications (1)
Number Date Country
20210046301 A1 Feb 2021 US
Provisional Applications (2)
Number Date Country
60654250 Feb 2005 US
60625644 Nov 2004 US
Continuations (8)
Number Date Country
Parent 15887777 Feb 2018 US
Child 16938296 US
Parent 15235683 Aug 2016 US
Child 15887777 US
Parent 14939895 Nov 2015 US
Child 15235683 US
Parent 14268489 May 2014 US
Child 14939895 US
Parent 13205463 Aug 2011 US
Child 14268489 US
Parent 12917412 Nov 2010 US
Child 13205463 US
Parent 11417675 May 2006 US
Child 12917412 US
Parent 11267822 Nov 2005 US
Child 11417675 US